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Characterizing Dietary Intake and Physical Activity Affecting Weight Gain in
Kidney Transplant Recipients
Abstract
Weight gain following kidney transplant is a significant problem with 50 to 90% of kidney transplant
recipients gaining weight. Potential factors leading to weight gain following kidney transplantation have
been thought to include a change in lifestyle such asdietary intake and physical activity, along with the
use of immunosuppressant medications to preserve the newly implanted organ. Other influences
affecting weight gain include genetic determinates such as age, gender and race. There is little data to
confirm which of these factors may indeed lead to weight gain and obesity. The purpose of this study was
to examine dietary intake and physical activity of kidney transplant recipients at baseline, 3 and 6 months
following transplantation to identify contributing factors to weight gain.
Methods: This descriptive, correlational study included secondary data to examine dietary intake, physical
activity and other variables (e.g., age, race, gender and medications) associated with weight gain post
kidney transplant for 44 participants, 18 years or older. Three 24 dietary intake recalls (1 weekend day and
2 weekdays) and 7 day-physical activity recalls (7D-PAR) were collected at baseline, 3 months and 6
months post transplant. Nutrition Data System for Research (NDS-R), a Windows-based dietary analysis
program, versions 2007, 2008 and 2009, (developed and coordinated by the Nutrition Coordinating Center,
University of Minnesota, Minneapolis, Minnesota) was used to analyze dietary data. Weights were done at
baseline, 3 and 6 months. Descriptive statistics and analysis of variance (ANOVA) for repeated measures
were used to compare nutrient and physical activity changes. Pearsons’ product-moment correlation
coefficient was used to describe the relationship of weight gain to other variables from baseline to 3 and
6 months.
Results: In the total sample, weight gain increased from 172.46 ± 34.05 to 182.09 ± 38.38 from baseline
to 6 months, indicating a 6% increase in weight. Body Mass Index (BMI) increased by 5% from 26.40 ±
3.80 to 28.24 ± 4.17 from baseline to 6 months. By race and gender, African American (AA) males and
females gained 11.1 and 11.7 pounds, respectively, while Caucasian males gained 9.3 pounds and
Caucasian females gained 2.4 pounds. Dietary intake did not show statistical significance from baseline
to 6 months. By race and gender, kilocalories (p ≤ 0.05), total fat (p ≤ 0.035) and total carbohydrate (p ≤
0.048) intake was higher in males than females. African American females had higher intake of these
nutrients than Caucasian females. Hours of sleep for the total sample was reported as (p ≤ 0.02), which
showed a decrease in the number of hours from baseline to 6 months. Moderate activity (p ≤ 0.046)
showed a decrease in males and increase in females at 6 months. Hours per day of hard activity (p ≤
0.04) increased in Caucasian females at 6 months. No relationship was demonstrated among dietary
intake, physical activity and age, race, gender and immunosuppression at 6 months.
Conclusion: Kidney transplant recipients are at risk for weight gain from a number of factors. Little
consideration has been given to what kidney transplant recipients are eating and the effects of dietary
intake on weight gain. Physical activity data from this study suggest that kidney transplant recipients are
not changing their physical activity levels significantly by 6 months following transplantation. Further
studies using a larger group should be considered.
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ABSTRACT
Weight gain following kidney transplant is a significant problem with 50 to 90%
of kidney transplant recipients gaining weight. Potential factors leading to weight gain
following kidney transplantation have been thought to include a change in lifestyle such
as dietary intake and physical activity, along with the use of immunosuppressant
medications to preserve the newly implanted organ. Other influences affecting weight
gain include genetic determinates such as age, gender and race. There is little data to
confirm which of these factors may indeed lead to weight gain and obesity. The purpose
of this study was to examine dietary intake and physical activity of kidney transplant
recipients at baseline, 3 and 6 months following transplantation to identify contributing
factors to weight gain.
Methods: This descriptive, correlational study included secondary data to
examine dietary intake, physical activity and other variables (e.g., age, race, gender and
medications) associated with weight gain post kidney transplant for 44 participants, 18
years or older. Three 24 dietary intake recalls (1 weekend day and 2 weekdays) and 7
day-physical activity recalls (7D-PAR) were collected at baseline, 3 months and 6
months post transplant. Nutrition Data System for Research (NDS-R), a Windows-based
dietary analysis program, versions 2007, 2008 and 2009, (developed and coordinated by
the Nutrition Coordinating Center, University of Minnesota, Minneapolis, Minnesota)
was used to analyze dietary data. Weights were done at baseline, 3 and 6 months.
Descriptive statistics and analysis of variance (ANOVA) for repeated measures were
used to compare nutrient and physical activity changes. Pearsons’ product-moment
correlation coefficient was used to describe the relationship of weight gain to other
variables from baseline to 3 and 6 months.
Results: In the total sample, weight gain increased from 172.46 ± 34.05 to 182.09
± 38.38 from baseline to 6 months, indicating a 6% increase in weight. Body Mass Index
(BMI) increased by 5% from 26.40 ± 3.80 to 28.24 ± 4.17 from baseline to 6 months. By
race and gender, African American (AA) males and females gained 11.1 and 11.7
pounds, respectively, while Caucasian males gained 9.3 pounds and Caucasian females
gained 2.4 pounds. Dietary intake did not show statistical significance from baseline to 6
months. By race and gender, kilocalories (p ≤ 0.05), total fat (p ≤ 0.035) and total
carbohydrate (p ≤ 0.048) intake was higher in males than females. African American
females had higher intake of these nutrients than Caucasian females. Hours of sleep for
the total sample was reported as (p ≤ 0.02), which showed a decrease in the number of
hours from baseline to 6 months. Moderate activity (p ≤ 0.046) showed a decrease in
males and increase in females at 6 months. Hours per day of hard activity (p ≤ 0.04)
increased in Caucasian females at 6 months. No relationship was demonstrated among
dietary intake, physical activity and age, race, gender and immunosuppression at 6
months.
Conclusion: Kidney transplant recipients are at risk for weight gain from a
number of factors. Little consideration has been given to what kidney transplant
v

recipients are eating and the effects of dietary intake on weight gain. Physical activity
data from this study suggest that kidney transplant recipients are not changing their
physical activity levels significantly by 6 months following transplantation. Further
studies using a larger group should be considered.
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CHAPTER 1. INTRODUCTION
Overview
Kidney transplantation remains the treatment of choice for many persons in endstage renal disease. More solid organ transplants are being done throughout the world
with life expectancy in some kidney recipients to exceed 40 years.1 With post transplant
obesity and cardiovascular related issues being prevalent following transplantation, the
focus of transplant research should transition to factors associated with these outcomes.
These factors include lifestyle behaviors associated with nutrition and physical activity.
Weight gain following kidney transplant is a significant problem with 50 to 90%
of kidney transplant recipients gaining weight.2 Findings from studies indicate a mean
weight gain of 10 kg (22 pounds) in the first year after transplantation.3-4 In earlier
studies, weight gain during the first year was reported equal to or greater than 10%.5,6
More recently results from a large retrospective review of weight gain and body
mass index (BMI) changes in the first year following kidney transplantation, Cashion and
colleagues7 revealed weight gain ranging from 6.2 kg (13.6 pounds) to 32 kg (70.4
pounds). As a result of weight gain, there has been an increase in morbidity and mortality
in kidney transplant populations.8,9-12
Potential factors leading to weight gain following kidney transplantation have
been thought to include a change in lifestyle such as dietary intake without concomitant
increase in physical activity, along with the use of immunosuppressant medications to
preserve the newly implanted organ. Other influences affecting weight gain include
genetic determinates such as age, gender, and race2 and psychological factors related to
stress.13 However, there is little data to confirm which of these factors may indeed lead to
weight gain and obesity.
Dietary intake remains an important factor following transplantation as nutrientrelated complications impact outcomes following kidney transplantation.14 There also
exists a change in the nutrient needs following kidney transplantation with different
dietary recommendations for the early, later and maintenance phases post transplant.15-17
Several dietary-related factors may contribute to weight gain following kidney
transplantation including the transition from a restricted renal diet to one that is
unrestricted, increased food intake resulting from feelings of well-being, and increased
appetite and body fat composition from corticosteroids.2,16
Little is reported in the literature regarding the relationship of dietary intake to
weight gain in post-kidney transplant recipients. Researchers in Mexico report
significantly higher ingestion of proteins and fats than recommended dietary reference
intakes (DRIs (p ≤ 0.05) in kidney transplant recipients in eight states in Mexico. As
would be expected, body mass indexes (BMIs) were higher in those transplant recipients
with the higher intakes of proteins and fats compared to those with less dietary intake of
1

these macronutrients.17 Other researchers recommend the importance of managing weight
gain through dietary counseling and follow-up to prevent significant weight gain leading
to obesity in kidney transplant recipient.6,7 Studies by Lopez and colleagues18 and Patel4
have shown that dietary interventions with follow-up in the early post transplant period,
can be effective in preventing excessive weight gain and that these dietary interventions
may lead to weight loss.
In addition to dietary intake, physical activity levels following transplantation
may influence the amount of weight gained. Post-transplant activity may be limited
resulting in decreased energy expenditure leading to post-transplant weight gain.19 In
2001, Neilens and researchers20 reported on average, 25% less physical activity in their
post-kidney transplant recipients compared to healthy subjects. Weight gain progressively
increased in their participants over the five years studied.
Activity or exercise is suggested by other researchers as an intervention in the
prevention of weight gain following kidney transplantation but no specific guidelines are
given.6,21 Long-term management of weight could possibly be achieved through regular
physical activity following kidney transplant.22
Immunosuppressant medications, needed for successful allograft maintenance,
may be an additional factor in weight gain following kidney transplantation. The
prolonged administration of medications such as high doses of corticosteroids can lead to
adverse side effects including weight gain. Immunosuppressant medications can also
affect body fat distribution and the retention of excess fluid may cause weight gain in the
post transplant recipient.2,23 Significant hyperglycemia and post transplant diabetes are
also common side effects of not only corticosteroids, but also seen with other
immunosuppressive agents such as cyclosporine and tacrolimus.24
In addition, cyclosporine, tacrolimus and sirolimus, along with corticosteroids
may contribute to the metabolic changes following kidney transplantation as the body is
attempting to adjust from its previous state of uremia. These medications, coupled with
changes in metabolic and body composition alterations put these recipients at risk for
cardiovascular events.1
Recently, steroid free or early steroid withdrawal protocols have been employed
following kidney transplantation25 to reduce or eliminate side effects such as weight gain.
However, results of several studies have demonstrated similar weight gain following
kidney transplant in participants on steroid-free protocols as well as those on steroid
protocols.6,26,27
Genetic factors including age, gender and race may be factors leading to weight
gain following kidney transplantation. Several studies report a genetic predisposition
related to race and gender.4,7,28 Correlates of weight gain following kidney transplantation
were found higher in African Americans than in Caucasians and higher in females and
younger patients.6
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In addition, psychological factors can also affect weight gain in these patients.
Psychological factors related to stress are common among patients following kidney
transplant.13 Among the stressors are fear of organ rejection and the fact that patients
must continue contending with a chronic illness.29
Detection of patients at risk for weight gain and obesity in the period following
kidney transplantation combined with early intervention and monitoring may prevent or
delay development of co-morbid disease leading to morbidity and mortality. With longer
survival rates in post transplant kidney recipients, risk factor management, particularly
management of cardio-vascular risk factors related to weight gain need additional study
for the reduction of these and other weight-related outcomes.2
Problem Statement
Weight gain following kidney transplantation is a significant problem. Comorbidities associated with weight gain in kidney transplant recipients include post
transplant diabetes and cardiovascular disorders. Increased dietary intake, low levels of
physical activity and the effects of immunosuppressant medications could contribute to
weight gain following kidney transplantation. To tailor better dietary and physical
activity interventions to transplant recipients, dietary and physical activity following
kidney transplantation need to be characterized. In addition, associations among these
contributing factors need to be established. By identifying contributing factors to weight
gain in this population, tailored interventions can be planned and implemented to abate a
significant increase in weight following kidney transplantation.
Purpose
The purpose of this study was to examine dietary intake and physical activity of
kidney transplant recipients at baseline, 3 and 6 months following transplantation to
identify contributing factors to weight gain. Using data from a larger longitudinal
prospective study entitled “Genetics, Environment, and Weight Gain Post-transplant,” the
secondary data analysis answered different questions than proposed in the parent grant.
Long term goal of the study was to use the identified factors associated with weight gain
following kidney transplant to design individualized dietary and activity protocols that
can be tailored to these recipients to avoid clinically significant weight gain in the first
year following transplant. This would lead to a decrease in co-morbid conditions
potentially decreasing mortality among at-risk individuals.
Specific Aims
1. Characterize micro and macronutrients in kidney recipients’ dietary intake at
baseline, 3 months and 6 months following transplantation.
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2. Characterize physical activity at baseline, 3 months and 6 months following
kidney transplantation.
3. Determine the relationship among dietary intake, physical activity, and other
factors (i.e., age, gender, race, medications) to weight gain in post kidney
transplant recipients.
Questions
1. Do kidney transplant recipients increase their food and calorie intake following
transplantation, and if so, to what extent and at what time point?
2. Do kidney transplant recipients increase their physical activity following
transplant and, if so, to what extent and at what time point?
3. What is the relationship of dietary intake, physical activity, and other factors (i.e.,
age, gender, race, and medications) to weight gain in post-kidney transplant
recipients?
Significance of the Study
Weight gain following kidney transplantation can progress to obesity leading to
poor health outcomes including coronary artery disease, hypertension, hyperlipidemia,
and post-transplant diabetes.3,30 The leading cause of death in long-term kidney transplant
recipients was cardiovascular disease.31
There is lack of evidence as to why some kidney transplant recipients
progressively gain weight. Moreover, there is little information on dietary intake of
kidney transplant recipients reported in the literature. To date, few interventional trials
have been conducted examining dietary intake and weight gain in the early transplant
period.
Low activity levels following kidney transplantation may play a role in the
development of weight gain. Individuals with end stage renal disease generally
experience a sedentary lifestyle which can continue following transplantation. These
recipients can experience muscle de-conditioning, exercise intolerance and fatigue.
There is currently a gap in the literature reporting macro and micronutrient intake
and physical activity of post kidney transplant recipients. The issue of weight gain
following kidney transplantation is a significant area of research to determine which
individuals are more at risk and how unintentional weight gain can be avoided. This
secondary data analysis addressed the issue of weight gain following kidney
transplantation. If successful, explicated the relationship of dietary intake and physical
activity to weight gain and serves as a foundation for interventional studies in this area.
4

Definitions of Terms
Terms will be defined as they are used in the study. Terms to be defined include
nutrient, macronutrient, micronutrient, and dietary reference intakes (DRIs).Other terms
defined are physical activity, immunosuppression, weight gain and body mass index
(BMI).
For this study, the term nutrient is defined as constituent substances in foods
necessary for chemical processes related to human tissue conservation, growth and repair.
These food constituents are proteins, fats, carbohydrates, vitamins, minerals and water.32
Macronutrients, organic substances made up of carbon compounds, include
carbohydrates, triacylglycerols (i.e., fats or lipids) and proteins or amino acids. These
macronutrients serve as major energy sources for the human organism; hence, large
quantities are required for cellular functioning. Excess substrates of these macronutrients,
not used for energy are stored by the body for use later.32
Micronutrients are substances essential in small quantities for metabolic functions
and growth and are not used for energy. Organic micronutrients are known as vitamins,
while inorganic micronutrients are known as minerals.32
Dietary reference intakes (DRIs), are defined as reference values that are
measurable or quantifiable for dietary intake of micro and macronutrients. DRIs also
refer to the highest bounds for a nutrient intake that is deemed safe for human
consumption.33
Weight gain is defined as added body mass when adipose tissue is stored. This
can result from an imbalance in caloric intake as opposed to calories expended.34 If
energy is not spent from the caloric intake from foods, then the individual stores the
excess energy in the form of fat or adipose tissue. According to Hill and Melanson,34
genetic and environmental factors also play a role in this energy balance, or imbalance,
leading to weight gain from extra stored fat.
Body mass index (BMI) is defined as a number representative of a person’s height
in relation to weight. It can be calculated by an individual’s weight measured in
kilograms, divided by the square of a person’s height in meters (kg/m²). According to the
World Health Organization’s (WHO’s) classification of BMI in 2010, underweight is a
BMI of less than 18.5. Normal weight is considered for a BMI up to 24.9. BMI equal to
or greater than 25 constitutes overweight status. Pre-obese classification has been added
and is a BMI of 25.00-29.99, while obesity is classified as a BMI equal to or greater than
30. The WHO further delineates the classifications of obesity as: obese class I, 30.00 34.99; obese class II, 35.00-39.99; and obese class III, equal to or greater than 40.00.35
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Physical activity is defined as movement in the body through skeletal muscle
action producing energy usage above resting metabolic state. This movement in the body
does not have to be categorized as exercise, as some activity can be divided into light
activities such as slow walking and standing. Walking briskly, lifting weights and yoga
are examples of physical activities that produce energy above a basal level and are
considered beneficial in lowering risk of some types of health issues such as diabetes
mellitus and cardiovascular related disease.36
When categorizing activities, the term metabolic equivalent (MET) is defined as
the ratio between metabolic rate when working and metabolic rate at rest.37 Activities can
be divided into light, moderate, hard and very hard activities according to the intensity.
Physical activity lasting 10 minutes or longer and of at least moderate intensity, are used
to assess energy expenditure in some clinical trials.37,38
Immunosuppression is defined as a medical therapy used to obstruct the body’s
natural defense mechanisms inherent in the immune system to the newly transplanted
kidney. This is achieved through the use of immunosuppressant medications to preserve
the functioning of the organ and to avoid allograph rejection.39 The balance of
immunosuppression is important to prevent graph rejection as well as prevent
superimposed infections, certain types of malignant tumors and to lessen or avoid side
effects.40,41 During and immediately after kidney transplantation, when acute allograph
rejection is highest, the induction phase of immunosuppression is started followed by a
maintenance phase.24,41 Common immunosuppression currently used following kidney
transplantation include calcineurin inhibitors (CNIs) such as cyclosporine and tacrolimus
or FK560 (Prograf), mycophenolate mofetil or MMF (Cellcept), mammalian target of
rapamycin (mTOR) or (sirolimus) and corticosteroids (prednisone and
methylprednisolone).41,42
Assumptions
This study had several assumptions about the association between dietary intake,
physical activity, immunosuppression and weight gain following kidney transplantation:
1. Dietary intake increases from baseline to 3 and 6 months post transplant,
contributing to weight gain.
2. Low levels of activity are maintained for most transplant recipients that mirrors
activity prior to transplantation and is a contributing factor to weight gain.
3. Immunosuppression is a contributing factor to weight gain following
transplantation.
4. Women will, in general, gain more weight than men following kidney
transplantation.
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5. African-American participants will, in general, gain more weight than Caucasian
participants following kidney transplantation.
Limitations
This study used 24-hour dietary intake recalls as a method of assessing micro and
macronutrient intake. This type of dietary intake assessment is a self-report and relies on
participant memory to recall the previous day’s dietary intake. Researchers have
identified that compared to healthy controls, kidney transplant recipients show increased
difficulty in cognitive measures such as learning and memory.43 These findings suggest
that memory could be affected in some kidney transplant recipients, thus impacting their
ability to accurately recall dietary intake. In contrast, researchers report an improvement
in memory in kidney transplant recipients when compared to their cognitive functioning
prior to transplantation.44 These data suggest that improvement in cognitive functioning
following kidney transplantation might be a positive factor in these transplant recipients’
ability to recall dietary intake data.
Although there are limitations with this type of data collection, some strengths of
the 24-hour dietary intake are built into the Nutritional Data System for Research (NDSR), the nutrient data system used for analysis. With this nutritional data system, dietary
intake data are obtained using a multisystem approach. This allows the recipient multiple
chances to recall dietary intake. Opportunities to provide detailed descriptions of foods
and to describe portion sizes are also a part of the system.45 In the United States, the 24hour dietary recall method is the type of dietary assessment most often used for collection
of dietary intake.46
Another limiting factor in this study was the use of a 7-day activity recall, which
requires participants to recall the previous 7 days’ activities, including a summary of the
previous 3 months’ activities. This type of activity recall also relies on the memory of
participants. It also does not take into account specific factors such as gender, age and
body type when estimating how much energy is used in activities.47 However,
participants are encouraged to recall as accurately as possible and are reminded of the
importance of data that will assist in identifying factors leading to weight gain.
There are also limitations such as participant dropout and graft loss which are
inherent when conducting clinical research with kidney transplant recipients. These were
controlled for in data analysis.
The inability to generalize the findings of this study to other kidney transplant
populations was an additional potential limitation. Although several adjacent southern
states are represented by the participants in this study, all recipients were recruited from
the same urban transplant clinic. However, the sample was racially diverse, as almost
equal numbers of African-American and Caucasian recipients participated in this study.
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Conceptual Model
The framework that guided this study included the key variables of dietary intake
and physical activity and their association to weight gain following kidney
transplantation. The relationships among variables such as age, gender, race and
immunosuppressant medications to weight gain following kidney transplantation were
examined. The conceptual model for this study is depicted in Figure 1.1.
Justification for selecting these variables included literature searches related to
previous research in post kidney transplant recipients. A gap in the literature was noted,
with little nutritional data reported, although a few interventional trials have been
conducted examining dietary intake, weight gain, and the impact of metabolic syndrome
in the early transplant period.1 Further justification for characterizing dietary intake was
that past research targeted allograph rejection and advances in immunosuppression
medication regimes in order to preserve the newly transplanted kidney. With post
transplant obesity and cardiovascular related issues being prevalent following transplant,
the focus of transplant research now is shifting to clinical nutrition.1
In all likelihood, transplant recipients return to a diet high in calories, fat and
carbohydrates once they no longer have to follow a highly restricted renal diet. In
addition, resolution of uremia after transplantation makes food taste better and may result
in additional intake. Increased appetite and treatment with immunosuppressant
medications may also be factors in weight gain following kidney transplantation.15
Because there is a gap in the literature characterizing dietary intake following kidney
transplantation to weight gain, it was a primary variable in the conceptual framework.
Physical activity following kidney transplantation may be limited, resulting in
decreased energy expenditure leading to post-transplant weight gain.19 Neilens and
colleagues20 reported 25% less physical activity in their post-kidney transplant recipients
compared to healthy subjects and progressive weight gain over a 5 year period. Because
few studies characterize physical activity in post-kidney transplant recipients and it has
been shown to be strongly associated with weight gain across populations, it was another
primary variable in the conceptual framework.
Non-modifiable factors such as age, gender, and race may predispose a transplant
recipient to weight gain. Age has been shown to be a correlate of weight gain in some
studies, with younger adults gaining more weight than older adults following kidney
ransplantation.6,28 Women have been shown to gain more weight than men post
transplant. When comparing African American recipients to Caucasians, there is a greater
weight gain at 1 year in African Americans.3
Immunosuppression medications have been implicated in previous studies as
having a significant association with weight gain.48 However, early withdrawal of
steroids is employed to limit weight gain following kidney transplantation.9,23,49 Elster
and researchers26 found that kidney transplant recipients gained weight regardless of the
immunosuppressant protocol.
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Figure 1.1 Post Transplant Weight Gain Model
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In the current study, most recipients were on four types of immunosuppression
medications, tacrolimus, mycophenolate mofetil, and sirolimus, along with prednisone.
Because there will be little variation, it was not expected to be a major factor in weight
gain following kidney transplantation.
Findings from this study contribute to existing knowledge about post-transplant
weight gain in kidney transplant recipients by identifying associations between various
nutrient intakes, levels of physical activity and medications post transplant as depicted in
the framework. Knowledge of significant weight gain at specific time points would assist
in guiding interventions and patient teaching regarding how to prevent weight gain. Pre
and post-transplant interventions regarding the types of nutrient intake, physical activity
and medications that contribute to weight gain could be devised in a collaborative effort
among nurses, physicians and dietitians. Detailed plans could be tailored to persons
awaiting transplant according to age, gender and race to prepare them for positive
outcomes post transplant. These data could be the basis for further interventional studies
with post-transplant recipients.
Summary of the Chapter
Following the problem statement, this chapter included a discussion of (a)
purpose, along with specific aims and questions, (b) significance, (c) definitions of terms,
(d) assumptions, (e) limitations, and (f) conceptual model of the study. The effects of
dietary intake, physical activity, and medications used for immunosuppression are
important factors that could lead to post transplant weight gain. As in the general
population, weight gain can lead to co-morbidities such as obesity, diabetes mellitus, and
cardiovascular issues; for post kidney transplant recipients; these co-morbidities can
occur with weight gain as well. The intent of this study was to determine the association
between dietary intake, activity, age, race, gender, and immunosuppression and weight
gain post kidney transplant.
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CHAPTER 2. REVIEW OF LITERATURE
This chapter presents pertinent literature related to the concepts in this study. The
first section provides research-based information related to weight gain in the general
population and in kidney transplant recipients. The second section addresses dietary
intake in kidney transplant recipients. The third section contains research-based
information on physical activity in post kidney transplant recipients. The next section
integrates transplant immunosuppressant medications and nutrient interaction. The final
section summarizes this chapter.
Weight Gain
Weight Gain in the General Population
Nationally, the prevalence of overweight and obese adults has been trending
upward in the United States over the past 40 years.50 In the most recent data related to
obesity in the National Health Examination Survey (NHANES), a sample of 8,082 adults
aged 20 and over, from both genders, showed 34.2% of adults in the United States were
overweight in 2007-2008, and 33.8% were obese. More men (72.3%) were overweight or
obese than women (64.1%).51
Globally, WHO estimates that 1.6 billion adults are overweight, while obese
adults number 400 million.51 Global increases predicted in the year 2015 could reach
about 2.3 billion overweight adults, while obese adults will be greater than 700 million.51
By the year 2020, if the trend in overweight and obese adults continues, it is predicted
that nearly half of the adults in the US will be obese, according to the World Health
Organization’s (WHO) criteria for obesity.52 Excess adipose tissue places individuals at
risk for the development of type 2 diabetes mellitus, hypertension, ischemic heart disease,
hyperlipidemia and other chronic diseases.51
Body mass index (BMI) is commonly used to categorize weight in individuals
using both the person’s height and weight for a more accurate representation of a
person’s body fat than just using weight itself. Researchers have shown that BMI is a
correlate of other methods measuring amount of body fat, such as dual energy x-ray
absorptiometry (DEXA) and measurement of weight underwater.53 BMI, used to assess
groups for classification of overweight and obese categories, is inexpensive to use and
allows individuals to compare their weight category to others. However, BMI is higher
in some groups and would not necessarily mean that an individual has excess fat tissue.
For example, athletes who have more muscle mass might be in a higher BMI category,
even though they do not have excess fat tissue.54
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Health Outcomes of Weight Gain in Healthy Adults
The impact of weight gain in healthy adults has serious health consequences, with
increasing morbidity and mortality.55 Weight gain leading to excess body weight is well
documented to be a prime risk factor for disorders of the cardiovascular system such as
coronary artery disease (CAD), hypertension and hyperlipidemia.55,51 Additional
disorders linked to excess body weight are type 2 diabetes, some cancers and disorders of
the musculoskeletal system.51 Not only does weight gain increase the prevalence of the
previously mentioned disorders, it can also cause exacerbations, or worsening, of existing
chronic disease in these individuals leading to more negative outcomes.55
Weight Gain in the Post Kidney Transplant Recipient
Weight gain and obesity have been noted in post kidney transplant recipients.3-5,7
In a retrospective review of 974 kidney transplant recipients between July 1993 and April
1998, weight changes were analyzed. At 1 year following transplantation, the mean
weight gain was 10.3 kg (22.6 lbs.), with a range of 75 to -23 kg or median of 10 kg (22
lbs.). Greater weight changes were seen in blacks (117.3%) compared to whites
(113.2%), p ≤ 0.0004. Women gained more than men (118.4% and 112.1%, respectively),
p ≤ 0.0001. Age showed an inverse correlation with weight gain (p ≤ 0.0002).3
Another retrospective review of 506 kidney transplant recipients between 1983
and 1999, reported at one year following kidney transplantation, African-Americans had
gained significantly more weight (13.6 kg) than whites (9.1 kg) and others (9.5 kg). This
increase in weight was also shown at 2 and 3 years following kidney transplantation with
mean weight gains for African Americans of 16.2 kg and 16.4 kg compared to
Caucasians, 11.5 kg and 11.1 kg at years 2 and 3, and 11.5 and 11.6 kg in others at years
2 and 3, respectively.48
In a prospective study of 50 kidney transplant recipients, researchers found that
mean weight gain for all participants was 4 kg (8.8 lbs), p ≤ 0.0001, for the first 6 months
following kidney transplantation. It was also noted that 30% (4 females, 11 males) of the
participants did not gain or lose weight during the first 6 months. More incidents of post
transplant complications, (i.e., allograft rejection and infection) occurred in the group that
did not gain weight or lose weight. Contributing factors in the group that did not gain or
lose weight could have been related to stress, catabolism, continued uremic state, delayed
sense of well-being and altered dietary intake related to hospitalizations and treatment for
rejection and infection. Females gained more than males (8 kg verses 7 kg, respectively).
Researchers concluded that early dietary intervention for female recipients might be
warranted, but further studies are needed to design weight control protocols.5
In a more recent prospective study, Cashion and colleagues7 found that there was
an increase in mean weight (6.2 ± 10.7 kg) during the first year following kidney
transplantation. Of the 171 individuals in the study, 70% were overweight or obese at the
time of transplant. This was compared to a group of individuals reported in the list
obtained from the United Network for Organ Sharing (UNOS) that indicated that 60% of
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those in the national database were overweight or obese at the time of transplant. This
indicates that not only is weight gain important to note following surgery but also many
of these transplant recipients are overweight or obese at the time of transplant. More
weight gain has been documented in patients who are moderately obese at the time of
transplant than in non-obese patients.3,56
El-Agroudy and research team23 documented that weight gain occurred in the first
6 months following transplant and that weight gain tended to increase after that but at a
slower rate. They speculated that this weight gain could be attributed to nutritional intake,
lessened rates of activity and a higher amount of steroids in their pharmacological
protocol.
A literature review done by Pischon and Sharma57 of nine studies in 2001,
indicated that significant weight gain in patients categorized as non-obese and obese was
seen in individuals after kidney transplantation. Weight gain in non-obese transplant
recipients was reported as 9 kg, as compared to obese individuals who gained 14 kg in
the year following transplantation.58 Still another study reviewed by Pischon and
Sharma’s57 reported weight gain of 8.5% in both non-obese and obese recipients 1 year
following transplantation.59 Similarly a 10.9% weight increase at 1 year post
transplantation increased to 15.3% over a 5-year period.6
These studies support that weight gain occurs in post kidney transplant recipients
regardless of the pre-transplant weight status. Weight gain is more pronounced during the
first year following transplantation.
Dietary Intervention Studies in Post Kidney Transplant Recipients
Some studies have tested dietary interventions in post kidney transplant recipients
to investigate weight gain and outcomes following transplantation. To determine the
effect of a dietary intervention on weight gain following kidney transplantations, Patel
and colleagues included 32 study participants in 2 groups. The intervention group (Group
A) was given individualized dietary advice for the first 4 months following
transplantation. This group, consisting of 11 participants (9 males, 2 females), was
followed prospectively for 1 year. In contrast, the second group (Group B) was not given
any dietary guidance or follow-up. Mean weight for Group A was 67kg ± 13 kg at
baseline, 69kg ± 12 kg at 4 months and 73kg ± 12 kg at 12 months compared to Group B,
mean weight 67kg ± 11 kg at baseline, 74kg ± 9 kg at 4 month and 79kg ± 12 kg at 12
months. Both groups gained weight; however, mean weight gain of 5.5 kg per recipients
was seen in the intervention group compared to a mean weight gain of 11.8 kg per
recipient in Group B. Researchers concluded that dietary intervention during the early
post transplant period, along with follow-up, could be a factor in limiting the amount of
weight gained during the first 12 months following kidney transplantation.4
In another nutritional intervention study involving 23 (16 females) kidney
transplant recipients, researchers in Spain reported mean weight loss was 3.2 kg ± 2.9 kg
after 6 months. Initial body weight (kg) was 77kg ± 13kg, with final body weight of 74
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kg ± 12kg (p < 0.001) for the total group. The dietary intervention used in this study was
the American Heart Association Step One pattern. Along with improvement in body
weight, there was an improvement in total cholesterol (237 mg/dL to 224 mg/dL; p <
0.05) in males, along with a reduction of low-density lipoprotein cholesterol of 136
mg/dL from 156 mg/dL, p < 0.05. Low-density lipoprotein values were not affected in
females following the nutritional intervention. Researchers concluded that obesity, as
well as hyperlipidemia could be reduced after dietary intervention.60
Improvement in body mass index (BMI) and metabolic syndrome were found
during the first year post kidney transplant by Bellinghieri and colleagues61 in 2009,
using a diet low in fat and calories. While tapering steroids, these investigators found that
with the dietary intervention, BMI could be reduced.
In 2007, Guida and colleagues,56 documented improvement in nutrition, body fat
and weight during the first year following kidney transplant by prescribing a low fat and
low calorie diet during their trial. In addition, improvements were seen in cholesterol
levels, fasting serum glucose and albumin. Data from a study by Guida and his research
team56 suggest that referrals made to dieticians early in the post transplant period, helped
to prevent weight gain. They found that by doing repeated dietary assessments on their
patients, they observed better compliance in their patients resulting in energy balance and
an improvement in their nutritional status. Consistent weight loss was demonstrated by
their patients, especially in males who followed a diet lower in protein, cholesterol and
sodium.
Health Outcomes Related to Weight Gain in Kidney Transplant Recipients
It is recognized that weight gain following kidney transplant poses undesirable
health outcomes, such as a higher incidence of cardiovascular disease (CAD), including
hypertension and hyperlipidemia, post transplant diabetes mellitus (PTDM) and
obesity.1,2,62 The leading cause of death in kidney transplant recipients is CAD.1
However, there are conflicting results in studies reviewing the effects of obesity on
outcomes following kidney transplantation.63
A retrospective review of 427 kidney transplant recipients between 1987 and
1992 reported that 50 of their participants developed atherosclerotic CAD in the posttransplant follow-up period, which was 28.6 ± 20.2 months. Coronary artery disease
occurred more frequently (9.8%), in their participants. Other cardiovascular-related
incidents were peripheral vascular disease (2.7%) and cerebrovascular disease (1.6%).
Forty-six percent of these 50 participants exhibited CAD prior to transplantation. Out of
the 427 recipients studied, 34 deaths occurred after transplantation of which 32.4% were
attributed to cardiovascular complications and 35.3% were related to infection—still
making deaths from infection as the main cause of mortality in this study.64
In a prospective study of 506 kidney transplant recipients between 1983 and 1998,
the most common cause of death (40%) was related to CAD. African Americans had the
highest frequency of death from cardiovascular disease (n = 20), followed by Caucasians
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(n = 7) and other (n = 5). Post-transplant diabetes (PTDM) had developed in 66 recipients
(32%) during the first year following kidney transplantation. Nonwhite participants
(African Americans and others) were two times more likely to develop PTDM than
whites.48
Dietary Intake in Kidney Transplant Recipients
Overview of Biochemical Processes in the Kidney Related to Nutrition
Biochemical processes in the kidney are complex and relate to nutrition by
regulating vitamin D, calcium and phosphorus, electrolyte balance (sodium, chloride,
potassium) and maintaining acid-base balance. Gluconeogenesis, amino acid metabolism,
fatty acid metabolism and maintaining water balance in the body are other biochemical
processes in the kidney.65
Prior to receiving a kidney transplant, individuals undergo hemodialysis, usually
for a number of years, as a treatment for end state renal disease (ESRD). Due to the
nonfunctioning kidneys, these biochemical processes in the kidneys are altered. Thus,
health care providers must consider the nutritional needs of persons in end-stage renal
disease and in the period following kidney transplantation.
Calcium homeostasis is an important biochemical process performed by the
kidneys related to the production of the active form of vitamin D, 1-25-dihydroxy vitamin
D or calcitrol. This active form of vitamin D facilitates the absorption of calcium and
phosphorus in the intestines. The kidney’s response to calcitonin and parathyroid
hormone is important in maintaining calcium balance.65,66
Calcium ions are necessary for all cells of the body and are important in the bone
mineral composition. Calcium ions are filtered in the glomerulus and are reabsorbed by
the renal tubules. This movement of calcium is accomplished through calcium channels
or by passive movement. Sodium/calcium exchangers, or Calcium adenosine
triphosphatase (calcium ATPase), is responsible for this ionic movement in the distal
tubules.65
Calcium binds with a protein, calbindin, within the cytoplasm. In order to
activate, calbindin requires 1, 24-dihydroxy vitamin D. The formation of 1, 24-dihydroxy
vitamin D is stimulated by parathyroid hormone, PTH, which also promotes excretion of
phosphate in the urine.65
Another important biochemical process in the kidney related to nutrition is the
active transport of potassium and sodium into and outside the cell. The enzyme sodium/
potassium adenosine triphosphatase (sodium/ potassium-ATPase), present in the
ascending loop of Henle and the proximal tubules has a role in this process. Through
active transport system which depends on ATP for energy, sodium chloride is reabsorbed
from the tubules into the peritubular space. D-glucose and amino acids are transported
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into the blood along with sodium. With leakage of potassium into the lumen, more
sodium is caused to move into the cell. Potassium is lost via both an active and a passive
system, thus potassium is always excreted regardless of the amount consumed. Sodium,
on the other hand can be decreased if little is consumed. Chloride ions are actively
transported along with the sodium ions.67
Involved in maintaining acid-base balance, hydrogen ions are secreted into the
urine via the proximal portion of the renal tubules by sodium/hydrogen exchangers and
hydrogen-ATPaseses. Hydrogen ions are used as substrates for the sodium/hydrogen
exchangers in the ascending loop of Henle, and excess hydrogen is excreted. Ammonia is
secreted by the α- intercalated cells forming ammonium. Bicarbonate is secreted by the βintercalated cells and reabsorbed in the tubules to maintain acid-base balance.
Gluconeogenesis occurs in the renal cortex but does not supply a significant amount of
glucose to the body. Fasting states increase gluconeogenesis, as does hormones of
epinephrine and glucagon by cAMP. During fasting states, fatty acids and ketone bodies
are the energy sources for gluconeogenesis, and phosphoenolpyruvate carboxykinase is
the enzyme. Acidotic states cause increase in messenger RNA, which increases the
production of this enzyme.68 Amino acid are catabolized through deamination, which
results in cleaving off an amino acid group from the molecule, resulting in ammonia and
keto acid. The kidney uses glutamine that is hydrolyzed to ammonium ion and glutamate,
which then gets oxidized to α-ketoglutarate. This process of ammonia production begins
with an enzyme, phosphate-dependent glutaminase, located within the matrix of the
mitochondria. During acidosis, ammonia is formed by increased activity of glutaminase
glutamate and by an increased transport of glutamine into the mitochondria.67 A small
amount of ammonia is excreted by the kidneys, with the remainder incorporated into
urea. Uric acid is formed by the degradation of purines, whereas the resultant nitrogen
from degradation of pyrimidine is excreted as urea in the urine.69
Creatine phosphate, found in muscle, is changed to creatine and excreted by the
kidneys. Since creatine is not reabsorbed by the renal tubules, it is used as a measure of
kidney function.69
Finally, maintaining water balance in the body is achieved through the kidney’s
ability to stabilize fluid volume and regulate osmolarity of body fluids. The kidneys have
the ability to remove excess substances and water and to conserve deficit substance and
water.
One of the mechanisms to explain fluid balance is in reference to plasma
osmolarity. The ratio of NaCl to total body water is affected by excess or decreased
amounts of water. Physiological feedback mechanisms assist in stabilizing plasma
osmolarity. Feedback mechanisms for blood volume and blood pressure changes also
affect thirst and excretion of water through the kidneys.70
Circulating arginine vasopressin (AVP), a small peptide made up of amino acids,
is responsible for regulating the concentration of the urine, whereas, aquaporins, or
transport proteins, primarily AQP-2, are responsible for transporting water in the tubular
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epithelium. The binding of AVP to receptors activate adenylate cyclase which increases
cyclic AMP to activate AQP-2 to move the water. The opposite functions occur when
AVP is removed and AQP-2 water channels are reincorporated back into the cell, so the
membrane is no longer permeable to water.70
Dietary Recommendations for Pre-transplantation Period
It is important in the pre-transplantation period to manage recommended dietary
intake in individuals with chronic kidney disease (CKD) to maintain muscle mass, create
a positive nitrogen balance and to prevent increased fat mass. The effects of CKD and
hemodialysis impact the nutritional state of individuals awaiting kidney transplant. An
increasing issue in these individuals is the number of overweight or obese persons
awaiting transplantation, as 60% of obese transplant recipients were reported between
1987 and 2001.71 These individuals in the pre-transplant period should be monitored by
health care providers to maintain optimal nutritional status and to prevent some nutrient
related complications post transplant such as overweight or obesity.
According to the National Kidney Foundation’s Kidney Disease Outcome Quality
Initiatives (KDOQI),72 recommendations for daily energy intake in individuals with end
stage renal disease (ESRD) is similar to recommendations in healthy adults. Based on
metabolic studies of persons being treated for ESRD by maintenance hemodialysis,
KDOQI72 recommends 35 kcal/kg/d for those below 60 years of age and 30 to 35
kcal/kg/d for those older than 60, according to their level of physical activity, to maintain
neutral nitrogen balance.
Protein intake for persons in ESRD has been a controversial issue in the literature.
As noted in the KDOQI guidelines, these persons can be malnourished due to a number
of causes, including poor nutrient intake related to decreased appetite, depression and
acidemia. Issues with amino acid removal with the dialysate as well as the hypercatabolic
nature of the illness or dialysis may also contribute to poor nutritional status. Daily
protein intake is currently recommended at 1.2 g/kg weight/d. This amount for protein
intake would likely produce neutral or positive nitrogen balance for most persons who are
clinically stable.73 Traditionally, protein intake has been restricted to 0.6-0.8 g/kg/day,
but now, may be reserved for those persons not on dialysis, to slow the progression of the
disease.74
The percent fat intake would be tailored to the individual related to cardiovascular
risk factors but is generally recommended to be 20-30% of the energy intake.74 If high
risk for CVD is present, then the recommendations are less than 10% saturated fat and
250-300mg cholesterol per day.66 Percent carbohydrate should make up the remainder of
the nonprotein calories75

17

Dietary Recommendations following Kidney Transplantation
The management of dietary intake recommendations for kidney transplant
recipients with functioning allografts impact outcomes related to morbidity and
mortality.25 Dietary recommendations for the renal transplant recipient in the early posttranplant period is recognized by Blue76 as 4–6 weeks following surgery and defined by
Wilkinson77 as the first 3 months post-transplant. With functioning allograft, kilocalorie
requirements are specified as 30–35 kcal/kg body weight/day and protein 1.3–
2.0g/kg/body weight/day.16,25 Meeting adequate needs for energy and protein to prevent
post operative complications of infection, decreased wound healing and loss of muscle
mass is a goal of nutritional intervention. These recommendations would also promote
calcium and phosphorus balance to minimize bone loss in these recipients.15 Percent
calories from fat are recommended at 30–35%,16 and percent calories from carbohydrates
at 50%.16,76
In this early transplant period, normal kidney functioning is supported and
continues to be established and maintained. During this time, kidney transplant recipients
have certain dietary recommendations to support their hemodynamic and electrolyte
balance. Mineral recommendations for these individuals include sodium intake of 3000–
4000 mg per day if unrestricted. However, if hypertension, edema, fluid retention and
absence of urine output are issues, sodium intake is restricted.16 In the presence of
hypertension related to calcineurin inhibitors sodium would be restricted to 2000 mg
daily.25 In contrast, 80 to 100 mmol/day (1440mg–1800 mg) of sodium intake is
recommended in the 2009 Australian Evidence-Based Guidelines for the Nutritional
Management of Adult Kidney Transplant Recipients to manage hypertension.14 Sodium
intake recommendation of 1300–2300 mg is recommended for the general population in
the absence of hypertension.66
Potassium intake of 4700 mg daily is recommended in post kidney transplant
recipients,76 as in the general population66 and would be restricted to 1000–3000 mg in
hyperkalemia, hypercalcemia and/or oliguria.16 As with sodium, serum potassium can be
elevated with the use of CNIs and thus would necessitate potassium restriction.77
Calcium recommendation is 1000–1500 mg/day with supplementation as
necessary76 which is similar to recommended adequate intake of 1000 mg per day. A
recommendation of 1200–1500 mg daily of phosphorus is noted16 and is higher than the
adequate intake amount of 700 mg recommended for the general population.66
Hypophosphatemia is an issue in the early post transplant period due to phosphaturia16
and is seen in about a fourth of recipients with proper allograft functioning, sometimes
requiring supplementation of dietary phosphorus. Magnesium recommendations are 200–
300 mg daily15 may need to be supplemented in the diet.76 This is lower than the
recommended daily intake of magnesium for males (400–420 mg) and females (310–320
mg) in the general population.66
For the prevention of long-term complications associated with post-transplant
recipients such as excessive weight gain leading to obesity, hyperglycemia, hypertension,
hyperlidemia, hypercholesterolemia and osteoporosis, goals of care would target these
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co-morbid conditions. To tailor caloric needs to the individual to attain or maintain
desirable weight, calories would need to be adjusted. Protein recommendations would be
0.8 to 1.0 g protein/kg body weight, based on serum albumin levels and assessment of
patient status. Carbohydrate intake of simple sugars is discouraged to maintain blood
glucose and avoid weight gain. Dietary fiber of 25–30 g/day is encouraged to assist in the
maintenance of blood glucose and cholesterol levels and in the prevention of excessive
weight gain. Limiting fat intake to 30% or less with 10% or less saturated fat, 10%
polyunsaturated fat and the rest from monounsaturated fats in accordance to the
American Heart Association (AHA) guidelines for Americans would help with
maintaining cardiovascular health while also limiting cholesterol intake to 300 mg
daily.76
Fluid and electrolytes, as well as vitamins and minerals should be tailored to the
individual as previously discussed in the early transplant period. Restriction or
supplementation would depend upon monitoring serum levels of these nutrients on a
regular basis post-transplant.
Macro Nutrient Intake Post Kidney Transplant
Very few research studies report the micro-and macro nutrient intake following
kidney transplantation. A cross-sectional study by Pulgar and colleagues17 reported the
macronutrient intake in 119 (56% males) kidney transplant recipients from eight states of
Mexico attending the Mexico National Olympiad. Macronutrient consumption obtained
through 24-hour dietary recall was analyzed for nutrient composition using the e-dossier
nutrition program.
In Mexican states that border the United States of America (USA), BMIs were
higher (≥ 25 kg/m2) among those transplant recipients compared to BMIs in states in
Mexico that do not border the USA. Significantly higher ingestion of proteins and lipids
than recommended DRIs (p < 0.05) was also demonstrated in these border line states in
Mexico than in other states in Mexico. Of the states showing higher intake of proteins
and lipids, the state of Nuevo Leon had the highest intake of percent fats (30.22 ± 0.8) as
compared to recommended 25.6 ± 0.7. Researchers suggested that these results could be a
reflection of the industrialized nature of the states bordering the USA and mirroring the
USA’s dietary intake practices.17
In a prospective study during the first year following kidney transplantation,
Haggan and colleagues investigated outcomes of nutritional markers and body fat
composition in 44 post kidney transplant recipients. A dietary protocol of 30 to 35
kcal/kg/d and 1.3 to 1.5 g/kg/d of protein recommended during the first 3 months
following transplantation. Fat intake was suggested at < 30%, cholesterol intake was
restricted to < 300 mg/d and simple sugars were restricted from dietary intake.
Participants completed a 3-d food record, recording all foods consumed.78 All
participants in the study,78 had a mean energy intake of 29.6 kcal ± 7.5 and a protein
intake of 1.1 g ± 0.4. The dietary intake of energy and protein steadily increased to the 6
month time point (32.6 kcl ± 7.2 and 1.36 g ± 0.33) and stabilized at 1 year (31.7 kcal ±
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6.4 and 1.33 g ± 0.31). Weight loss and a decrease in fat mass were seen by these
researchers in male recipients, suggesting that nutrition/dietary recommendations could
have a positive influence on weight gain post transplant.78
Dietary Reference Intakes (DRIs)
The term Recommended Dietary Allowance (RDA) is the former label used for
standards of gauging nutritional sufficiency since 1941. The current term, DRI, was
introduced in 1997 replacing RDA in the United States.79 Developed by the National
Academy of Sciences’ Institute of Medicine (IOM) of the United States Agricultural
Department (USDA), along with the government of Canada, DRIs also replace
Recommended Nutrient Intakes (RNIs), formerly used by Canada.79
DRIs, the current method of depicting reference standards related to identified
nutrients, include the previously used term RDA, along with the three other distinct
reference values. The four reference values included in the new DRIs are the estimated
average requirements (EAR), recommended dietary allowance (RDA), adequate intake
(AI) and tolerable upper intake level (UL). These four values can be used when planning
interventions for individuals and groups, as well as assessing dietary intake of these
entities. The advantage of having four reference values, as opposed to one reference
value (i.e., RDA), is that varied types of reference values can be applicable to
recommended nutrient intake for either individuals or groups.79
Most nutrients have EAR which have been established, as well as a corresponding
RDA, related to the EAR. If there is no established EAR, a related RDA has been
identified. In the case of no DRI (and thus no RDA), an AI has been determined. Other
nutrients have UL which have been established as the tolerable upper limit for that
nutrient to be acceptable.79
All of the DRIs represent an average of the daily nutrient intakes, similar to the
previously used RDAs and RNIs. This new set of four distinct DRIs now represents a
distribution of nutrient requirements as opposed to a single number.80
The first of these reference values is the Estimated Average Requirement (EAR).
This takes into account the daily projected nutrient intake quantity required by 50% of
healthy individuals accounting for gender and life stage.79 The second reference value,
RDA is developed from the EAR and is the dietary nutrient level needed on a daily basis
to fulfill the nutritional needs of almost all healthy persons (i.e., 97-98%), in order to
prevent or decrease the development of chronic disease. The RDA accounts for variation
in nutrient requirements within certain groups (i.e., males, females, children, persons over
70 years and lactating females). The third reference value is the Adequate Intake (AI).
This quantity is used when an RDA for a particular nutrient has not been determined
through research. It is used to establish goals for individuals to prevent chronic disease,
for example, to decrease fat intake for adults or to sustain a component of desired health
such as retention of calcium in bones.79 Finally, the Upper Limits (UL) reflects the upper
or highest level of average intake for a nutrient that will not create undo risk of
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unfavorable health issues in healthy individuals in the population. Intake levels exceeding
the UL could pose health risks.79
24-hour Dietary Recall
Several methods for collecting dietary intake data include food frequency
questionnaires (FFQ), diet histories, food record method and the 24-hour dietary recall.
The method used depends on the type of data needed. Advantages of 24-hour dietary
recall and the food record methods are that actual amounts of food and fluid consumed by
participants are reflected. Twenty-four hour dietary intakes and food records are
considered more accurate methods of assessing dietary intake as opposed to the FFQ and
diet histories.81
This current study used the 24-hour dietary recall method, the most widely
employed method of obtaining dietary intake data in the United States. This method has
been used by the National Center for Health Statistics for collection of dietary data for
the three National Health and Nutrition Examination Surveys (NHANES): NHANES I
(1971-1975), NHANES II (1976-1980) and NHANES III (1988-1994) and for NHANES
Hispanic subgroups.81,82 In addition, the 24-hour recall method has been used by the U.S.
Department of Agriculture Surveys and in clinical trials with nutritional components.81
There are other advantages of the 24-hour dietary recall as opposed to other
methods of collecting dietary intake data. Historically, the 24-hour dietary intake method
has been done in a face to face interview format with participants. More recently,
telephone interviews have become a common method of collecting dietary intake. The
two advantages of telephone interviews are apparent. The first advantage is that the
telephone precludes the need for the participant and interviewer to meet at a designated
location. This is especially useful when multiple days of dietary intake are obtained, as in
this study. The second advantage is that the interview can be done on a day that is
unexpected or unannounced to the participant, in the hope that their eating habits will not
be altered by the anticipated recall.81
Although there are advantages in telephone interviews when collecting 24-hour
dietary intake, there are some disadvantages. One disadvantage of collecting dietary
intake using telephone interview is the lack of ability to show pictures of food or to use
food models for participants to estimate food portion size. Other disadvantages to this
method are similar to those of face-to-face interviews including inaccurate reporting of
foods eaten and inability of participants to remember food intake from the previous day.
The interview situation could also lend itself to a potential bias in the responses of the
participants.83
The collection of dietary intake data using the 24-hour dietary recall method is
subject to a degree of error.84 However, the error of data collection using the 24-hour
dietary recall method can be reduced. The main source of error in data collection is the
participant’s memory. Skillful interviewers using prompting and probing questions
related to the participant’s preceding 24-hour dietary intake can assist participant’s recall
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of consumed food and fluid in the preceding 24-hour period. This can be accomplished in
part, by relating food intake to activities done during the previous day. A list of
commonly forgotten items such as candy, cookies, chips and drinks can also assist
participants to more accurately recall intake.81,85
Underreporting, another source of error of 24-hour recall of dietary intake, can
occur but may be reduced if participants are thoroughly briefed on the process of the 24hour dietary recall method. The use of a multiple-pass system allowing the interviewer to
use a hierarchical system while gathering more detail with each pass lessens
underreporting when gathering dietary intake data.81 Multiple-passes also allow the
interviewer to obtain more detailed descriptions of foods, lessening inadequate
description of foods as another source of possible error.85
The day- to-day variation in dietary intake in participants is a source of random
error, which is a part of dietary intake measurements. The multiple-pass approach, along
with multiple days, help to lessen this degree of error when gathering dietary intake
data.85
Another key aspect of gathering accurate dietary intake is the interviewer’s
emphasis on the importance of the participant’s assistance to the research. It is necessary
for the interviewer to stress the value of their contribution to the research study.81
Another source of error for the 24-hour dietary recall method is the estimation of
portion sizes by participants. This type of error can be reduced by the use of standardized
household measures such as teaspoons, tablespoons and cups and by estimating portion
sizes in three dimensions using inches.81
Finally, the motivation of the participants to accurately describe details necessary
for a thorough 24-hour dietary recall can be a source of error. The establishment of
rapport in a professional, nonthreatening manner, where participants feel free to respond,
can be a motivating factor for participants to more accurately respond to the interviewer.
Incentives to participants, such as money and the knowledge that they are contributing to
research, might also increase motivation.81
Reliability and Validity of 24-hour Dietary Recalls
A study conducted to assess the accuracy and precision of four different types of
dietary intake collection were compared in a small cohort of healthy young women (n =
20) and older women (n = 20). Food intake data was collected using 24-hour recalls, 7day weighed food intake data and food frequency questionnaires (FFQs) and 2 previously
validated FFQs. These four food consumption records were compared with total energy
expenditure (TEE) using doubly labeled water. The participants drank the doubly labeled
water and collected urine specimen for 8 days.
Results showed that of the four methods used, 24-hour recall method was more
congruent with TEE in younger women and that one of the FFQs, Willett FFQ, was
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closest for energy intake to TEE in older women. In this study, the more complex method
of 7-day weight dietary intake was no more precise than the other less complex methods.
Researchers concluded that although these dietary intake methods are considered suitable
for measuring energy intake, that further studies need to be done to determine accuracy of
these dietary intake assessment methods.86
Another study evaluating 24-hour recalls as compared to four-day food records,
reported that unannounced 24-hour recalls were the preferred method of collecting
dietary intake data as opposed to the 4-day food record. Although underreporting can be
present in all types of dietary intake data, these researchers suggest that through the use
of skilled interviewers asking probing questions, underreporting can be decreased. Their
data showed a relatively low level (8%) of underreporting which they attribute to the
manner in which their trained interviewers conducted the dietary recalls.87
A more recent study in Brazil using healthy women (n = 65) between the ages of
18 and 57 years comparing FFQ, food records and 24-hour recalls using doubling labeled
water, showed similar results. Less underreporting of energy intake was seen using the
24-hour dietary recalls and food records as compared to FFQ method.88
Nutrition Data System for Research (NDS-R)
The NDS-R was developed by the Nutrition Coordinating Center (NCC) at the
University of Minnesota in Minneapolis in 1974.89,90 In collaboration with the National
Heart, Lung and Blood Institute (NHLBI), the data system software was developed and
used for two research programs at its inception. This led to the establishment of the
Nutrition Coordinating Center (NCC) by the National Institute of Health (NIH), which
continues to be a renowned national center for research at the University of
Minnesota.89,90 Since then, the system has continued to change and grow into a
comprehensive research database used by hundreds of institutions in the United States as
a research instrument.90
The NDS-R is maintained by the NCC at the University of Minnesota and is
updated on a regular basis in order to reflect current foods consumed in the United States.
Ethnic foods as well as specific age group populations are included in the comprehensive
database.89,90
The comprehensiveness of this food and nutrient database is demonstrated by the
number of foods and food brands in the system. Currently, the NDS-R contains over
18,000 foods and 7,000 brands of food products. Prepared foods with ingredient choices
number more than 160,000 foods.91
A major part of the database is the nutrients contained in food. The nutrient list
currently contains 160 nutrients. Ratios of nutrients and other components related to food
such as energy sources, fat and cholesterol, carbohydrates, fiber, vitamins and minerals
are included. Other food components more recently added are carotenoids. Sugar alcohol,
amino acids, isofavones and other food components are a part of the system.91
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Another important feature of the database is the assignment of foods to food
groups, including fruits, vegetables, grains, dairy and alternatives, meats and meat
alternatives, fats, sweets, beverages and miscellaneous foods. These food group
assignments are further delineated into 166 subgroups.91
Still another feature that makes this database attractive to researchers includes the
standardization of the system using published imputation. For example, to have a
complete nutrient database, it is sometimes necessary to impute or calculate values from
similar foods as in ingredients in frozen dinners and the nutrients in each ingredient. This
can be done in a variety of ways including using values from a similar food or a different
form of the food, using calculations from recipes or nutrition labels, to name a few.92
Finally, updates to the system are made annually and released to licensed users.
These updates reflect many changes in the current food market. Analytic data is also
improved with each annual update.93
Specific studies when using NDS-R can design study specific protocols when
there is a questionable food or amount to enter into their data. These data entry rules are
established and recorded by the research team and made available to those collecting and
entering data. This information lends itself to more valid and reliable data entry since
consistency among team members are established.93
To meet the need for stability of nutrient database, several versions of the Food
Table remain available. Even with updates, the users for long term studies will have the
nutrient values determined for foods when the consumed foods were reported. At the end
of the study, investigators can determine to use the original nutrient content or the
updated versions as necessary.94
In order to evaluate validity and reliability, quality control measures to verify data
entry of various food sources, need to be part of a data system.92 Suggestions for quality
control include reviewing the system’s manual, editing any improperly entered data, or
data in error. Other quality control measures include consistency of the program among
the nutrient values of foods that are similar and consistency of nutrient contents within
foods. These are automatic in NDS-R. Data consistency is also maintained by comparing
nutrient values to algorithms of expected food values.92 If discrepancies are found
between the calculated algorithms, and what is contained in the database, nutrient ranges
are flagged and investigated by NCC personnel.
Another demonstrated means of maintaining validity and reliability includes the
standardized method of interviewing prompts that are included to guide the dietary recall
interview on various screens in the software. This method uses the feature of direct data
entry using an interactive process.95
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Another measure to ensure validity and reliability is NDS-R’s multiple-pass
method of obtaining the participant’s recall. This gives the researcher four occasions to
gather information for accuracy and completeness as previously discussed.95
Still another means of validity and reliability is demonstrated by the number of
reviews of the data. The first review is with the participant, second is when the
investigator reviews the data following the interview and thirdly by confirming amounts
on any data entry errors.95 Standardization of food portions using household measures
such as cups and teaspoons/tablespoons increase validity and reliability of the data
received and entered.
To further discuss validity and reliability, it is imperative that users of NDS-R
have documentation regarding how nutrients are calculated and the sources of
information used for this dietary data. The coding system in NDS-R designates the
reference source including the page number or a specific code from the source. Examples
of sources for nutrient data include the United States Department of Agriculture (USDA)
reference, scientific journals, food tables and other sources in which nutrient data can be
obtained. Researchers can determine the reliability of the nutrient data by the sources of
the data used in the food tables provided.94
In an ongoing attempt to maintain accuracy of the data base to maintain reliability
of data, NDS-R developers employ several methods of quality control to achieve this.
These include updating NCC Food Table on daily basis allowing for modifications in
nutrients. Another way includes periodic checks of accuracy for the “Reference Food
Table” by reviewing the algorithms used for calculations of nutrients for any deviations.
Finally tests can be done to check various calculations and compare to previously
calculated test records for nutrient values.94
Finally, inter-study comparability is also possible with NDS-R, which allows
investigators to compare nutritional data between studies done in the past and in the
future. Even foods that are no longer available on the market are maintained in the
database. Recalculated values as updates occur can be compared to older versions of the
food product.
In order to evaluate validity and reliability, quality control measures to verify data
entry of various food sources, need to be part of a data system.92 Reviewing the system’s
manual, editing any improperly entered data, or data in error, consistency of the program
among the nutrient values of foods that are similar and consistency of nutrient contents
within foods are automatic quality control features in NDS-R. Data consistency is also
maintained by comparing nutrient values to algorithms of expected food values.92 If
discrepancies are found between the calculated algorithms, and what is contained in the
database, nutrient ranges are flagged and investigated by NCC personnel. Still another
means of validity and reliability is demonstrated by the number of reviews of the data.
The first review is with the participant, second is when the investigator reviews the data
following the interview and thirdly by confirming amounts on any data entry errors.95
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Standardization of food portion visuals, graphic paper and food amounts booklet using
measurements also increase validity and reliability of the data received and entered.
Reliability and validity of the NDSR has been well established. Since its inception
in the 1970’s, the database has been used in many clinical investigations for analysis of
dietary intake. Its use has been identified in trials related to cancer, cardiovascular disease
and hypertension, and in gastrointestinal and bone health disorders.89
Physical Activity in Kidney Transplant Recipients
Along with nutritional management, physical activity and conditioning play a role
in the prevention of secondary complications (i.e., obesity) following kidney
transplantation. Kidney transplant recipients generally show an improved capacity for
activity and exercise as compared to their pre-transplant level.25
Health Benefits in Kidney Transplant Recipients
Physical activity on a regular basis following kidney transplant is important for
several reasons. The possibility of minimizing weight gain while lowering risks of comorbidities such as cardiovascular disease and diabetes is of primary importance.77
Improvement in quality of life and feelings of well being are also desirable.96
However, conditions developing prior to transplantation, such as fatigue and
muscle de-conditioning leading to weakness, are obstacles for physical activity. Poor
motivation for physical activity many also be a barrier.96,97
Following kidney transplantation, cardiac output may be reduced due to a number
of reasons such as cardiomyopathies, which could limit some types of activities such as
aerobic exercise.96 Blood pressure is also affected in kidney transplant recipients due to
denervation of the transplanted kidney, so blood pressure could be higher in these
individuals following exercise.98
To illustrate these cardiovascular issues, researchers employing a prospective
research design tested exercise capacity in 16 kidney transplant recipients for 2 years
following transplantation. Peak oxygen consumption (VO2 max) was significantly lower
in the transplant recipient group compared to the healthy control group at 1, 4 and 10
months but not at 16, 24 and 48 months. VO2 max did not show improvement in these
participants after 16 months. The reason for this decrease in VO2 max was thought to be
the adverse correlation of VO2 max with resting systolic blood pressure prior to exercise
(r = -0.26, p ≤ 0.039), suggesting a lack of normotensive parameters in the sample.
Echocardiographic structural changes and VO2 max were negatively correlated with
diastolic diameter of interventricular septum (r = -0.37, p ≤ 0.004) and systolic diameter
interventricular septum (r = -0.38, p ≤ 0.003). Negative correlations were also seen in left
ventricular end-systolic volume (r = -0.49, p ≤ 0.043) and VO2 max. These researchers
conclude that exercise capacity of post kidney transplant recipients is lower than healthy
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controls and suggest future studies of a larger prospective nature to see if permanent
improvement of cardiovascular issues and exercise capacity can be achieved with these
transplant recipients.99
In another prospective study designed to follow 32 kidney transplant recipients
for 5 years, researchers administered two validated questionnaires through interviews, the
Baeche and the Five City Project 7-day recall to post kidney transplant recipients. These
participants were interviewed about their pre-transplant physical activity about 15 days
after transplantation. They were also interviewed using the two instruments at 1, 3, 6 and
12 months following transplantation. Due to participant loss to follow-up, only 18
participants were available to interview at the 5-year time point.20
These researchers found that compared to healthy controls, the transplant
recipients were significantly less active and scored between 18% and 35% lower at the
pre-transplant interview. However, physical activity showed a significant increase within
the first year in these transplant recipients and showed ~ 30% mean physical activity
level increase which was significantly different from pre-transplant physical activity
levels.20
7 Day-Physical Activity Record (7D-PAR)
This study used the 7 Day-Physical Activity Report (7D-PAR) to assess physical
activity at baseline and at three and six months following kidney transplantation. The 7DPAR is an instrument for gathering self-reported physical activity recall from participants
through the use of interview, either face to face or per telephone. Moderate, hard or very
hard exercise performed continuously for at least ten minutes is recorded. Time spent in
light activities and sleep is recorded for the previous seven days.100
When classifying activities by their required energy, the term of metabolic
equivalent (MET) is used. This method of describing energy expenditure takes into
account the ratio of working to resting metabolic rate. Activities are classified and
assigned a number according to their MET as follows: sleep – 1 MET; light activity –
1.0–2.9; moderate activity – 3.0–5.0; hard activity – 5.1–6.9 and very hard activity –
>7.0.100
Some difficulties have been identified with use of the 7D-PAR. First, interviewers
need to be trained in the use of the 7D-PAR to gather data and to classify the METs for
activities. Second, the time required per interview is approximately twenty minutes and
may discourage its use with some researchers. Last, as with any self-reported data, the
participant’s ability to recall the previous seven days of activity, along with ambiquity of
certain activities, may be an issue. However, use of the 7D-PAR with populations can
characterize their activity levels, requires an acceptable amount of time to gather data and
is appropriate for use in studies to gain knowledge about a particular study group.100
Various studies have examined the validity of the 7D-PAR. Test-retest reliability
using 64 participants showed a Pearson correlation of r = 0.83, (p < 0.0001) between
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amount of reported vigorous activities. More variability was seen in Pearson’s correlation
in moderate activity (r = 0.75, p < 0.0001). Reliability coefficients varied for other
components but these researchers reported stable means during the 2 week testing
interval. Reported factors possibly attributing to these variations in reliability coefficients
were gender and being overweight. Reliability of reporting energy expenditure was
higher in males than females, demonstrated by Pearson’s correlation.100
Criterion validity, along with reporting error factors, was examined in a
moderately overweight group of young adult, both male and female, using doubly labeled
water (DLW) with healthy controls. Two measures from the 7D-PAR, total daily energy
expenditure (TDEE) and physical activity energy expenditure (PAEE), were compared to
the healthy controls of young adults using doubly labeled water. The 7D-PAR and DLW
were used to calculate PAEE. Significant differences in TDEE were not found between
the 7D-PAR and DLW. No significant difference was found in mean PAEE from 7DPAR and DLW. These data show that mean TDEE and PAEE were reliable estimates for
group means but may not be reliable for calculation of individual PAEE.101
Another means of evaluating reliability and validity of self reported data from the
7D-PAR was compared with data from triaxial accelerometer (RT3) during July 2002 and
August 2004 in a random clinical trial. One hundred thirty-nine recent breast and prostate
cancer survivors participated in a diet and exercise intervention. Moderate agreement
between the 7D-PAR and accelerometer was demonstrated at baseline (r = 0.54), 1 year (r
= 0.24) and 2 years (r = 0.53) with all p values < 0.01. For moderate-to-vigorous physical
activity, estimates were higher with the accelerometer. These data show modest
agreement between self-reported physical activity and accelerometer.38
Compendium of Physical Activities
The Compendium of Physical Activities originally developed by Ainsworth and
colleagues47 in 1993 is a coding method for physical activities. Self- reported physical
activity data surveys, as well as physical activity logs and records, can be coded for use in
observational studies. A five digit code represents certain physical activities of different
intensities using metabolic equivalent intensity level (MET). Resting metabolic rate when
an individual is sitting quietly is representative of one MET. The Compendium contains
lists of activities that are multiples of this resting MET state. For example, sleeping is
represented by 0.9 while running at 10.9 miles per hour is designated by 18 METs. The
updated Compendium includes a supplementary list of activities representing suggested
additions from researchers over the past ten years. Various other types of daily activities
and their MET values have been added to the Compendium to represent interests of
public health research.37
Value and Limitations of Using the Compendium
When using the Compendium for research, it is important for investigators to
record only the time the participant spends in actual movement when energy costs or
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METs are measured. The original intent of the Compendium was not to measure absolute
energy requirements of certain activities, but instead, proposes a means of classifying
physical activities in a standardized manner so that MET intensities could be estimated.37
A limiting factor to the Compendium is that factors such as age, gender, body
types and body fat compositions are not considered. Other factors such as environment
and ease of bodily movements are not accounted for in individual differences when
calculating MET levels. Some activities contained in the Compendium are not based on
indirect calorimetry. Similar activities may have similar MET values giving altered
confidence levels around mean MET values for those activities.37
Immunosuppression following Kidney Transplantation
Adequate immunosuppression is crucial to maintaining the new transplanted
kidney. The balance is a delicate one, preventing rejection of the allograft while avoiding
the effects of over-suppression leading to infections, cancers and side effects, such as
nephrotoxicity, that could threaten the transplanted kidney.102 Along with preserving the
newly implanted kidney, another goal is to decrease the long-term side effects of
immunosuppressant medications. The benefits, compared to the risks of chronic steroid
administration, are being questioned, causing a paradigm shift to steroid taper regimens
or steroid free protocols used in some practices.103
Immunosuppressant medications currently used in clinical settings are described
as using a T-cell activation and proliferation model. This model is made up of three
signals causing T cells to activate. During the first signal, T-cell receptors are triggered
by antigen-producing cells (APCs) causing a specific antigen signal which leads to the
antigen being transduced through the CD3 complex.41
The second signal results in secretion of interleukin-2 (IL-2) and other cytokines.
This is caused by the interaction of B7 on the APC and CD28 on T cells. Activation of
mammalian target of rapamycin (mTOR) is achieved through stimulation of the IL-2
receptor (CD25). This second process causes the third signal to initiate leading to cellular
proliferation.41
Immunosuppression is represented by two distinct phases known as induction and
maintenance. At the time of transplantation, or during induction, monoclonal or
polyclonal antibiotics are used targeting specific processes in the immune system. The
maintenance phase continues during the recipient’s life and usually consists of a
combination of medications including corticosteroids, calcineurin inhibitor (CNI) and
antiproliferative agent.24
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Dietary Aspects of Immunosuppressant Medications Affecting Weight
Although the use of immunosuppressant medication is vital to the preservation of
the new implanted kidney, these medications have side effects. One of the possible side
effects of corticosteroids and immunosuppressant medications is weight gain.
Corticosteroids or glucocorticoids, directly affect carbohydrate metabolism.
Blood glucose concentration in the blood is caused by gluconeogenesis in the liver. At
the same time, blood glucose is increased, uptake of glucose into other cells such as
muscle, adipose and lymphatics is decreased. This decrease use of glucose peripherally
and an increase blood glucose causes insulin to be secreted. These glucocorticoids also
increase appetite and promote fat deposits in the face and neck area.104
Corticosteroids have been used for over 40 years in immunosuppressive regimens.
However, some centers are now tapering steroids in the early transplant period while
others are employing steroid free protocols.
Corticosteroids used over long periods of time have side effects that are well
documented. Side effects such as weight gain, hypertension, hyperglycemia, and posttransplant diabetes, along with increased blood lipid levels, impact cardiac co-morbidities
following kidney transplantation. Muscle wasting affects could also impact physical
activity following kidney transplant.24
Several classifications of immunosuppressant medications are currently used in
clinical practice. These include corticosteroids, calcineurin inhibitors (CNIs), mTOR
inhibitors and antiproliferative agents.
The CNIs prevent the synthesis of interleukin (IL)-2. Common to the kidney
transplant recipients in this study is tacrolimus, a CNI which binds to proteins inside the
cells of cyclophilin (FK-binding protein). This intracellular binding process leads to
inhibition of IL-2 mediated T cell activation and prevents proliferation of lymphocytes.24
Posphatase activity is inhibited by the resultant drug-protein complex leading to
diminished IL-2 synthesis.105
Because tacrolimus (Prograf) is metabolized by the cytochrome P450 enzyme
system in the liver, the possibility of drug and food interactions can occur. For example,
grapefruit or grapefruit juice are known to reduce or inhibit the P450 system, thus
changing levels of CNIs metabolized by the same metabolic pathway in the liver.24
Tacrolimus has other side effects such as posttransplant diabetes, hypertension,
hypomagnesemia and hyperkalemia. Magnesium supplements and low potassium diet are
used to treat these electrolyte imbalances following kidney transplantation.24
The mTOR inhibitor, sirolimus, has a different mechanism of action than the
CNIs. The binding of sirolimus to calcineurin at the FK binding protein then binds
mTOR interfering with cell replication at the G1 to S phase. Metabolism of sirolimus also
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occurs in the cytochrome P450 system, making drug-food interactions as stated earlier
with CNIs a potential issue.24
Side effects of sirolimus having dietary implications include alterations in
triglycerides and cholesterol. Diarrhea and other gastrointestinal disturbances can also
impact dietary intake and absorption of nutrients from dietary intake. Modification of
diet, use of antilipid medications and omega-3 fatty acids (fish oil) have been useful in
the treatment of lipid abnormalities associated with the use of sirolimus.106
Finally, the last classification of immunosuppressant medications prescribed to
participants in this study are the antiproliferative agents, namely MMF (Cellcept). The
active compound in MMF is mycophenolic acid (MPA) which inhibits an enzyme,
inosine monophosphate dehydrogenase (IMPDH). IMPDH affects the denova synthesis
of purine affecting production of quanosine nucleotides from quinine. This action in turn
has antiproliferative effects on lymphocytes which rely on denova synthesis of proteins.
It has no effect on cytokine production, unlike calcineurin inhibitors and sirolimus.107
Side effects of MMF that would impact nutrition are nausea and diarrhea.
Recipients on MMF experiencing gastrointestinal symptoms could have poor dietary
intake resulting in decreased kilocalories and weight loss. These side effects can be
lessened by reduced dosage and shortened intervals between doses.24
The potential dietary interactions of these medications require monitoring
following kidney transplantation. Dietary issues present prior to transplant should be
addressed. Follow-up after kidney transplantation should address potential issues such as
weight gain and other side effects mentioned that could affect dietary intake in the
months following transplantation.
CNIs Affecting Weight Gain following Kidney Transplantation
A retrospective study of 99 kidney transplant recipients between 1988 and 2006
assessed the effects of two types of calcineurin inhibitors on weight gain following
kidney transplantation. The first group of recipients received cyclosporine A (CyA),
while the second group was prescribed tacrolimus (Tac). Both groups received
prednisolone in addition to either Cya or Tac, and either mycophenolate mofetil (MMF),
azathioprine or interleukin-2 receptor antagonists. Prednisolone was progressively
reduced at the first, second and sixth months. Weight gain was statistically significantly
increased (p < 0.01) after six months. Twelve month weight gain was 3.8 kg ± 6.8 kg in
the Tac group and 8.7 kg ± 7.8 kg in the CyA group. Although both groups gained
weight, more weight was gained by the group using CyA which suggests that the type of
immunosuppression could affect the amount of weight gained following kidney
transplant.108
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Summary of the Chapter
In summary, weight gain is an issue in the general population and in kidney
transplant recipients following transplantation. Evidence-based information is
documented regarding the health outcomes in the general population and some research
done in post kidney transplant recipients report similar co-morbidities related to weight
gain. A body of knowledge is lacking in the dietary intake practices of individuals
following kidney transplantation. Weight gain is pronounced in the first year following
kidney transplantation with a slower trajectory of weight gain after the first year
following transplantation. Studies suggest that increased calorie intake without
concomitant increase in physical activity lead to weight gain in these individuals. Even
though some physical activity investigations have been done, intervention studies
designed along with prescriptive dietary interventions could impact the amount of weight
gain in these individuals. As per the findings in some of the studies in the review,
immunosuppressant medications may also play a role in weight gain following kidney
transplantation, but the evidence is not clear as to which medications affect weight gain
in individuals post transplantation.
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CHAPTER 3. METHODOLOGY
Research indicates that weight gain leading to obesity following kidney
transplantation is a significant problem. Relationships between weight gain and comorbid diseases have been established. Factors including increased dietary intake, low
physical activity and immunosuppressant medications have been suggested as the cause
of weight gain. However, there is little data documenting dietary intake and physical
activity of kidney transplant recipients. Thus, this study set out to characterize micro and
macronutrient intake and physical activity in persons following kidney transplantation. In
addition, this study determined if associations exist between dietary intake, physical
activity, immunosuppressant medications and weight gain following kidney
transplantation. This chapter describes the methodology of this study including research
design, setting, sample, and procedures.
Research Design
A descriptive, correlational study included secondary data to examine dietary
intake, physical activity, and other factors (e.g., age, gender, race, and
immunosuppressant medications) associated with weight gain following kidney
transplantation. All participants were enrolled in a larger 5-year, prospective longitudinal
study examining genetics (expression profiles), environmental factors (e.g., dietary intake
and physical activity) associated with weight gain leading to obesity following kidney
transplantation. Dietary intake and activity recalls were done via face to face interviews
in the university hospital’s kidney transplant clinic or by telephone interview at baseline,
three and six months. Clinical data were obtained through the university hospital’s
electronic records or by charts located in the transplant clinic.
Sample
This secondary data analysis provided examination of dietary intake, physical
activity and other variables (e.g., age, gender, race, immunosuppressant medications)
associated with weight gain post kidney transplant. After obtaining institutional review
board approval, dietary intake, physical activity and clinical data were used from
participants enrolled in a larger, 5 year longitudinal study exploring environmental and
genetics factors and their association to weight gain and obesity after kidney
transplantation. The participants in the parent transplant obesity study were transplanted
between August 2007 and August 2009 at a large Midsouth university-hospital-based
transplant institute. The inclusion criteria for the parent study included 18 years of age or
older, must be able to read and understand English. Exclusion criteria for the parent study
included receiving steroid therapy prior to the time of transplantation.
Forty-eight participants who had reached their 6 month time point and had
baseline, 3 and 6 month dietary, physical activity and weight data were considered for the
secondary data analysis. Participants were excluded if they lost greater than 10% body
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weight from baseline to 6 months. Blackburn and colleagues109 identified weight loss
greater than 10% in a 6 month period as significant. This percent weight change usually
accompanies poor oral intake or medical illnesses110 and indicates a state of protein
malnourishment, impacting immune functioning, morbidity and mortality.109 This study
looked at dietary intake, physical activity and age, gender, race, and immunosuppressant
medications and their association to weight gain, thus excluding the four participants who
had lost greater than 10% body weight in the first 6 months following kidney
transplantation.
Four participants (1 African American male, 1 African American female, 1
Caucasian male, 1 Caucasian female) were excluded because they had lost more than
10% of their baseline body weight at 6 months. Thus, 44 participants (22 males and 22
females) who had signed informed consent for the parent study and had reached their 6
month time point since transplantation were included in this secondary data analysis.
To minimize a threat to confidentiality, participant identification numbers were
used. All data was password protected in a computer database. Consent forms were kept
in a separate locked cabinet. Participant confidentiality was in compliance with the
Health Insurance Portability and Accountability Act (HIPAA) guidelines for electronic
data. Participants in the parent study had been informed about data collection, usage and
storage to conform to HIPAA regulations. No other potential risks were identified.
Setting and Recruitment
A large teaching hospital located in the south eastern United States was the
recruitment site for the larger parent study. Participants were recruited by core team
members of the parent study either in the kidney transplant clinic or at various renal
dialysis clinics. Consent forms were signed by the participants after a thorough
explanation by core team members. Following approval by the university’s Institutional
Review Board the principle investigator of the parent study provided deidentified data
and the secondary data analysis was conducted.
Procedures
For this study, dietary and physical activity data from baseline, 3 and 6 months
post-transplant time points were used. Participants in the larger longitudinal prospective
study had been informed of the various time points (baseline, 3 and 6 months) that dietary
intake and activity recalls would be obtained. Most of the recall data were done per phone
during regularly scheduled appointments in the transplant clinic. Twenty-four hour
dietary intake was obtained at baseline and at 3 and 6 months following transplantation to
include one weekend day and two weekdays of food and fluid. Seven-day activity recall
interviews were done at baseline and again at 3 and 6 months post-transplant. BMI was
calculated on all participants at their pre-operative workup visit to the clinic. Weight was
measured at baseline and at the 3 month checkup and at the 6 month checkup using the
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medical scales in the transplant clinic. Age, gender, race and immunosuppressant
medications and other clinical data were obtained in the larger prospective longitudinal
study by reviewing chart information in the clinic or by reviewing the electronic medical
record.
Dietary intake, physical activity data and clinical data were downloaded from the
two databases where data had been entered for the larger longitudinal study. Dietary data
from output files generated by NDSR were downloaded into a Microsoft Excel
spreadsheet before exporting into Statistical Package for the Social Sciences, Predictive
Analytic Software 18 for Windows™ (SPSS/PASW) version 18.0 (SPSS, Inc., Chicago,
IL). Each nutrient variable of interest was maintained in the Excel spreadsheet. The
physical activity data and clinical data were downloaded into a Microsoft Excel
spreadsheet. Dietary intake, physical activity and clinical data were then merged into one
single file for analysis of the variables of interest.
Managing the data in the study, including data cleaning and preparation were
necessary steps before data analysis could take place.111 Data cleaning of the dietary data
involved inspecting each nutrient value for outliers in comparison to a reference DRI
value. If extreme values for participants were found, verification of the data was made by
reviewing the original data from the handwritten 24-hour dietary recall. After that,
subsequent review of the data entry into NDS-R was performed to check for any data
entry errors. If one or two days of the three days of dietary intake was present at a time
point instead of all three days, means were imputed using the available data or a mean of
the nutrient for the group was used for a missing value.112
Physical activity data were downloaded from the storage database for the larger
longitudinal study into an Excel spreadsheet before importing into SPSS for analysis.
Cleaning the data involved inspecting for outliers and other irregularities. Any
questionable data such as excessive amounts of physical activity were verified by first
checking the original 7 D-PAR interview document where data were recorded and
comparing it to data entered into the database for analysis.
When creating the secondary analysis files, the names of the variables and the
coding decisions were entered into an electronic codebook. Each variable was carefully
named to ensure easy recognition of corresponding data in the spreadsheets when
imported into SPSS.
Once all of the data was in one spreadsheet, a second data cleaning was done to
ensure that all measurements and time points were congruently entered into the original
data. Because of data entry errors, weight entered into pounds was calculated into
kilograms. In addition, errors in time point coding were corrected.
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Instruments
In this study, empirical data were obtained using the following approaches: (a)
three day 24 hour dietary intakes entered into the Nutritional Data System for Research
(NDS-R), (b) 7 Day-Physical Activity Record (7D-PAR) and (c) clinical data from
transplant recipient chart reviews of electronic kidney transplant clinic records.
Dietary Intake
3 Day 24-Hour Dietary Recalls
Dietary intake records consisted of 3 weekday recalls and 1 weekend recall.
Participants were informed that each diet recall would take about 20-30 minutes in the
larger longitudinal prospective study. The participants were contacted by phone regarding
the dietary recall or interviewed face to face in the transplant clinic while awaiting a
scheduled appointment. These unannounced dietary recalls were obtained using a multipass prompted script interview. Participants were given three chances to give as much
detail about the diet intake as possible. Diet data was verified by the investigator before it
was entered into the computer. Data was analyzed by the NDS-R for Windows software
into nutrient components including micro and macronutrient values.
The 24-hour dietary recall method employs an interview situation with trained
research personnel to gather explicit information about a participant’s food and fluid
intake for the previous 24-hour period. Probing questions are used to gather sufficient
detail about the consumed dietary intake starting with the first time of the day that the
participant had anything to eat or drink and progressing forward. The accuracy of the 24hour recalls is dependent upon the skill of the interviewer, as well as the memory of the
participant about the previous 24-hour period.81
Validity of the 24-hour dietary recall method has been established through the use
of this method in dietary surveys in the United States. Twenty-four hour recalls have
been used to gather dietary diet in multiple government initiatives such as by the National
Center for Health Statistics and the National Health and Nutrition Examination Surveys,
as well as numerous large research studies.81 If describing the mean intake of a group is
the purpose of the study, then a single 24-hour dietary recall is the appropriate method.
Multiple days of dietary recall are considered by some experts to give more dietary
information and is considered to be the gold standard when assessing the dietary intake of
individuals. The one day, 24-hour recall can yield valuable data when obtained through
prompting and clarification by the interviewer.113
Several strengths are associated with the 24-hour recall method. Because this
method is based on actual reported intake, estimated intakes of kilocalories, and microand macronutrient absolute values rather than relative values can be determined.
Specificity of information is enhanced through the use of detailed descriptions of foods
reported by the participants using a structured interview process. Details regarding foods
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(e.g., sources, preparation method and amounts) can be obtained to answer research
questions.
Another major strength of the 24-hour dietary recall method is that literacy issues
are not a hindrance to the use of 24-hour dietary recall. Participants are not required to
read or complete any written material.
The validity of this method is strengthened since it is generally an unannounced
or unexpected event which lessens the chances of participants altering their dietary intake
patterns.87 With 24-hour dietary intake recalls taking 20 to 30 minutes on average,
participant burden is also decreased.81
Limitations of the 24-hour dietary recall method have been identified. A major
limitation is that this method does rely on participant memory to call the previous 24hour food and fluid intake. Generally with this method, foods are not weighted or
measured. The approach relies on the participants’ estimation of sizes and descriptions.81
Limitations are discussed further in the limitations section in Chapter 4.
NDS-R
The use of computer software for data entry related to nutrition and dietary recall
and its analysis of nutrients and other food components have aided nutrition research. The
Nutrition Data System for Research (NDS-R), developed by the Nutrition Coordinating
Center (NCC) at the University of Minnesota, is a Windows-based dietary analysis
program used for entry and analysis of dietary intake. Considered the “gold standard” for
dietary analysis, it contains data for 160 nutrients and food constituents, and is updated
yearly to reflect changes in nutrient composition of foods and food market changes.90
Features of NDS-R include the comprehensiveness of this food and nutrient
database and the current nutrient list. These features are demonstrated by the number of
foods and food brands exceeding 18,000 foods and 8,000 brands of food products.
Prepared foods with ingredient choices number more than 160,000 foods.91 The nutrient
list currently contains 160 nutrients. Ratios of nutrients and other components related to
food such as energy sources, fat and cholesterol, carbohydrates, fiber, vitamins and
minerals are included. Other food components more recently added are carotenoids.
Sugar alcohol, amino acids, isofavones and other food components are a part of the
system.91
Reliability and validity has been established for NDS-R as a research database. It
is a research tool extensively used by hundreds of institutions collecting and analyzing
dietary intake.114 It has been used in a variety of clinical trials to calculate dietary intake
data for various dietary-related diseases.89 When comparing four nutrient databases (e.g.,
ESHA Food Processor, NDS-R, Moore’s Extended Nutrient Database, and Nutritionist
IV databases) with their chemical component data from a hypertension focus trial, the
four nutrient databases, intraclass correlation between the sites of data entry was 0.998.
Although some variance was noted among the four nutrient databases, it was small (<
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10%) for some nutrients. Measures of bias and precision showed significant differences
in some nutrients (e.g., kilocalories, saturated fatty acids, and polyunsaturated acids);
their corresponding laboratory values had a variance of < 15% with the exception of iron.
Accuracy and precision for the nutrients in this hypertension research study, performed
well in all of the four databases.115
To maintain validity and reliability of NDS-R, quality control measures to verify
data entry of various food sources, are a part of the data system.92 Quality control is
maintained by reviewing the system’s manual, and editing any improperly entered data,
or data in error. Other quality control measures include consistency of the program
among the nutrient values of foods that are similar and consistency of nutrient contents
within foods. These are automatic in NDS-R. Data consistency is also maintained by
comparing nutrient values to algorithms of expected food values.92 If discrepancies are
found between the calculated algorithms, and database entries, nutrient ranges are flagged
and investigated by NCC personnel. Other means of maintaining validity and reliability
include standardization of interviewing prompts, multiple-pass approach used during
interviewing, number of reviews of data, coding system for reference sources for nutrient
data and inter-study comparability.116
Physical Activity
Assessment of participant activity was accomplished using the 7 Day-Physical
Activity Recall (7D-PAR) interview. It has been widely used since the early 1980s as a
general measure of physical activity, either work related or non-work related, in a variety
of studies. Participants recall activity, sleep patterns and physical activity behaviors over
the preceding seven days during a structured face-to-face or phone interview. In addition
to sleep, classification of activity include moderate, heavy and strenuous based on the
instrument’s measurement criteria. Participants provide examples of activities and the
amount of time for each activity that fit the designated categories. Metabolic equivalent
(MET) value is assigned by the interviewer to various levels of activity based on the
updated Compendium of Physical Activity. A MET value is calculated as the ratio of
metabolic rate during work to the resting metabolic rate of 1.0 (4.18 kJ) kg-1·h-1.
Multiples of the resting MET level are used to assign values to activities with a range of
0.9 (sleeping) to 18 METs (running at 10.9 mph).37 The METs are then used to estimate
kilocalorie expenditure.
Test-retest reliability (r = 0.77, p ≤ 0.0001) was reported by Sallis and his team,117
in a cohort of children and adolescents, while comparing interviewers completing a five
session group training program, Gross and colleagues reported a test reliability of r = 0.99
in healthy individuals while testing the skills of interviewers.118 Convergent validity (r =
0.70, 0.66, p ≤ 0.05) examination was done comparing 7D-PAR with activity logs of men
ages 34-60 years.119
Still another study comparing validation of the 7D-PAR telephone interview
version to 7D-PAR face-to-face interviews using the same protocol, reported intraclass
correlation between the two methods for total minutes of activity for the total days as r =
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0.96, r = 0.94 for moderate, r = 0.97 for hard, and r = 0.97 for very hard activities. In
comparing the TriTrac-R3D accelerometer to the 7D-PAR phone interview, Pearson
product correlation for the total physical activity for the 7 days were r = 0.43, r = 0.31
(moderate activity), r = 0.39 (hard activity), and r = 0.78 (very hard activity). Pearson
Product correlation coefficients for the week comparing the face to face 7D-PAR and
TriTrac-R3D was r = 0.41, r = 0.33 (moderate activity), r = 0.43 (hard activity) and r =
0.74 (very hard activity). These data show that the 7D-PAR phone interview and the 7DPAR face to face methods were similar for obtaining self-reported activity from adult
participants. The results were also comparable to validated activity measured by the
TriTrac-R3D.120
Criterion validity of the 7D-PAR was evaluated in a group of young adult males
and females in the moderately overweight category using doubly labeled water (DLW).
The parameters assessed by the DLW were compared to total daily energy expenditure
(TDEE) and the physical activity energy expenditure (PAEE). The comparison of activity
expenditure measured by the DTW and the 7D-PAR showed no significant difference in
both males and females. Thus, the 7D-PAR is a practical means to estimate TDEE and
PAEE in groups.101
Clinical Data
Electronic and paper charts from the university hospital’s transplant clinic were
used to gather demographic information and clinical data at baseline, 3 and 6 months and
entered into the database for the larger longitudinal prospective study. Demographic
information included age, gender, race/ethnicity, education level and socioeconomic
information. Clinical data included date of transplant, number of hospitalizations
following transplant, immunosuppressant medications, pre-transplant history and diabetes
and hypertension and post transplant diabetes. Other data gathered included weight and
BMI at baseline, 3 and 6 months following transplant.
Data Analysis
Data analysis was accomplished through the use of the SPSS/PSAW version 18.0.
The dietary data were downloaded from NDS-R into an Excel spreadsheet for data
cleaning. Activity data were downloaded from a database used for activity data storage
was downloaded into an Excel spreadsheet. The data were then downloaded into
SPSS/PSAW v. 18 for analysis. Descriptive statistics will be used to describe the
participants with frequency distributions used to describe categorical data such as age,
gender, race and clinical data. Repeated measures ANOVAs were used to compare
nutrient changes and physical activity changes from baseline to 3 months to 6 months.
Pearson’s correlations were run on the dietary intake variables, physical activity variables
and age, gender, race and immunosuppressant medications to check for relationships of
these variables to weight gain. Data management included keeping all hard copies of data
in a locked cabinet with only participant identification numbers. Computers storing data
are password protected. NDS-R data is automatically saved every 24 hours in the system.
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Research Questions
Question 1. Do transplant recipients increase their food and calorie intake
following transplantation, and if so, how? Nutrient intake at baseline, 3 and 6 months
were obtained through 24-hour dietary recalls and entered into NDS-R. Caloric intake
was automatically calculated using NDS-R software for analysis. Repeated measures
ANOVA was performed to examine the differences in nutrient intake at the three time
points. Descriptive statistics were used to characterize the sample at the various time
points. An a priori significance of ≤ 0.01 was used with the ANOVA to reduce the risk of
type I error.
Question 2. Do transplant recipients increase their physical activity following
transplant and, if so, at what time point? 7D PAR recalls were obtained at baseline, 3 and
6 months via face to face report or telephone recalls. Repeated measures ANOVA was
performed to examine the differences in physical activity at the three time points.
Descriptive statistics were used to characterize the sample at the three time points. An a
priori significance of ≤ 0.01 was used with the ANOVA to reduce the risk of type I error.
Question 3. What is the relationship among diet, physical activity, and other
factors (i.e., medications, race, age, gender) to weight gain in post kidney transplant
recipients? Pearson’s correlations were run on the dietary intake variables, physical
activity variables and age, gender, race and immunosuppressant medications to check for
relationships in these variables to weight gain. This was done to examine if there is a
relationship in these variables and weight gain following kidney transplantation.
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CHAPTER 4. RESULTS AND CONCLUSIONS
Introduction
Weight gain following kidney transplantation is a significant issue. Fifty to 90%
of renal transplant recipients gain weight after transplant,2 with an average first year
weight gain of 22.7 to 25.0 pounds (10.3 to 11.8 kg).3,4 Data from a retrospective review
examining weight gain and changes in body mass index (BMI) categories during the first
year following renal transplantation in our transplant center demonstrated a significant
increase in weight of 13.6 to 70.4 pounds (6.2 kg to32 kg).7 This is significantly more
than the 1.8-2 pounds (approximately 0.9 kg) average yearly weight gain reported in
adults in the United States121 and the recommended lifetime increase of < 11 pounds (5
kg).122
Undoubtedly, obesity can be attributed to environmental factors such as increased
energy intake of kilocalories and decreased physical activity or expended energy.121 In
much the same way, it is believed that kidney transplant recipients increase their intake of
kilocalories due to an increase in appetite and removal from dietary restrictions imposed
in the management of chronic renal disease prior to transplantation, but do not increase
their physical activity appreciably following transplantation. However, there is little
documented about the food intake and physical activity levels of kidney transplant
recipients and the relationship of these environmental factors to weight gain.
Improved allograft outcomes have resulted from advances in immunosuppressant
therapies.62 As a result of improved appetite123 following renal transplantation, these
individuals are at risk for weight gain leading to obesity.23 Increased risk for
cardiovascular disorders is often attributed to obesity following kidney transplantation,30
and presently, the leading cause of death following kidney transplantation is
cardiovascular disease.124 Past research has targeted allograft rejection and advances in
immunosuppressive medication regimes to preserve the newly transplanted kidney. With
post transplant obesity and cardiovascular related issues being prevalent following
transplant, the focus of transplant research should now focus on clinical nutrition.1
The purpose of this study was to examine dietary intake and physical activity of
kidney transplant recipients at baseline, 3 and 6 months following transplantation to
identify factors contributing to weight gain. The following research questions were asked:
(1) Do kidney transplant recipients increase their food and calorie intake following
transplantation, and if so, to what extent and at what time point? (2) Do kidney transplant
recipients increase their physical activity following transplant and, if so, to what extent
and at what time point? (3) What is the relationship of dietary intake, physical activity,
and other factors (i.e., age, gender, race, medications) to weight gain in kidney transplant
recipients?
An increased awareness of the factors leading to weight gain following kidney
transplantation will facilitate the development of interventions to aid in the prevention of
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significant weight gain. A greater understanding of the environmental factors leading to
weight gain following kidney transplantation will assist health care professionals in the
development of tailored dietary and physical activity protocols to lessen or ameliorate
significant weight gain leading to obesity following kidney transplantation.
Methods
This descriptive, correlational study included secondary data to examine dietary
intake, physical activity and other variables (e.g., age, gender, race, immunosuppressant
medications) associated with weight gain post-kidney transplant. After obtaining
institutional review board approval, dietary intake, physical activity and clinical data
were used from participants enrolled in a larger, longitudinal study exploring
environmental and genetics factors and their association to weight gain and obesity after
kidney transplantation. The participants in the parent study were transplanted between
August 2007 and August 2009 at a large Mid-south university-hospital-based transplant
institute. The inclusion criteria for the parent study included (1) 18 years of age or older
and (2) able to read and understand English. Exclusion criteria for the parent study were
(1) receiving steroid therapy prior to the time of transplantation and (2) death or loss of
allograft.
Forty-eight participants who had reached their 6 month time point and had
baseline, 3 and 6 month dietary, physical activity and weight data were considered for the
secondary data analysis. Participants were excluded if they lost greater than 10% body
weight from baseline to 6 months. Blackburn and colleagues109 identified weight loss
greater than 10% in a 6 month period as significant. This percent weight change, usually
accompanies poor oral intake or medical illnesses,110 and indicates a state of protein
malnourishment, impacting immune functioning, morbidity and mortality.109 This study
looked at dietary intake, physical activity and age, gender, race, and immunosuppressant
medications and their association to weight gain, thus excluding the four participants who
had lost greater than 10% body weight in the first 6 months following kidney
transplantation.
Four participants (1 African American male, 1 African American female, 1
Caucasian male, 1 Caucasian female) were excluded because they had lost more than
10% of their baseline body weight at 6 months. Thus, 44 participants (22 males and 22
females) who had signed informed consent for the parent study and had reached their
sixth month time point since transplantation were included in this secondary data
analysis.
Data Collected/Procedure
For the parent study dietary intake, physical activity, heights, weights and BMI
were obtained from all participants at the time of transplant (baseline) and 3 and 6
months following transplantation. Dietary intake and physical activity recalls were done
by the same research team members who were well versed in gathering recall data.
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Heights, weights and BMI were measured and recorded by the transplant clinic personnel
in the electronic health record at the time of transplant and at 3 and 6 month check-ups
following transplantation. The same calibrated medical scales were used to weigh
participants at each time interval in the transplant clinic. Other clinical data collected
from the database included kidney donor sources, numbers of hospitalizations in the first
six months following transplantation, suspected rejection episodes, baseline incidence of
hypertension and diabetes, and immunosuppressant medications.
Using telephone interviews, dietary and physical activity recalls were obtained
after the first two weeks following transplantation. This period of time was considered to
be reflective of the return to regular eating patterns while physical activity recall to be
representative of activity and exercise engaged in the period just prior to transplantation.
Most of the recall interviews were conducted over the telephone or during
regularly scheduled appointments in the transplant clinic. Twenty-four hour dietary
intake was obtained at baseline and at 3 and 6 months following transplantation to
include one weekend day and two weekdays of food and fluid. Physical activity at
baseline and at 3 and 6 months was done by telephone recall using a 7 day recall of the
past week’s activity along with usual activity of the past 3 months. Age, gender, race and
immunosuppressant medications were obtained by reviewing chart information.
Dietary Intake
This study used the Nutrition Data System for Research (NDS-R) to assess dietary
intake at baseline, and at three and six months. Data were downloaded from the parent
study database The NDS-R, developed by the Nutrition Coordinating Center at the
University of Minnesota is a windows-based dietary analysis program used for entry and
analysis of dietary intake. Considered the “gold standard” for dietary analysis, it contains
data for 160 nutrients and food constituents, updated yearly to reflect changes in nutrient
composition of foods and food market changes.91
To evaluate validity and reliability, quality control measures to verify data entry
of various food sources, need to part of a data system.92 Reviewing the system’s manual,
editing any improperly entered data or data in error, consistency of the program among
the nutrient values of foods that are similar and consistency of nutrient contents within
foods are automatic quality control features in NDS-R. Data consistency is also
maintained by comparing nutrient values to algorithms of expected food values.92 If
discrepancies are found between the calculated algorithms, and what is contained in the
database, nutrient ranges are flagged and investigated by NCC personnel. Still another
means of validity and reliability is demonstrated by the number of reviews of the data.
The first review is with the participant, the second occurs when the investigator reviews
the data following the interview and the third is by confirming amounts on any data entry
errors. Standardization of food portions through the use of common household
measurements such as measuring cups and rulers also increase validity and reliability of
the data received and entered.
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Physical Activity
This study used the 7Day-Physical Activity Report (7D-PAR) to assess physical
activity at baseline and at three and six months following kidney transplantation. The 7DPAR is an instrument for gathering self-reported physical activity recall from participants
through the use of interview, either face to face or per telephone. Based on participants’
response to 7D-PAR recalls, five subsets of physical activity (sleep, light, moderate, hard
and very hard) were studied to see if physical activity changed from baseline to 3 and 6
months and if so, when this change in physical activity was reflected following kidney
transplantation. Kilocalories for the five subsets of activity were recorded as well as total
METs compared from each time point. In addition, number of days of moderate activity
was recorded. Moderate, hard or very hard exercise performed continuously for at least
ten minutes was recorded.100
Test-retest reliability (r = 0.77, p ≤ 0.0001) was reported by Sallis and his team117
in a cohort of children and adolescents. While comparing interviewers completing a five
session group training program, Gross and colleagues reported a test reliability of r = 0.99
in healthy individuals while testing the skills of interviewers.118 Convergent validity (r =
0.70, 0.66, p ≤ 0.05) examination was done comparing 7D-PAR with activity logs of men
ages 34-60 years.119
Data Analysis
Dietary intake, entered into a windows-based dietary analysis program during the
parent study was downloaded from the database. Data cleaning involved inspecting for
outliers. Any questionable data such as excessive amounts of nutrient intake were
verified by first checking the original document where data was recorded and comparing
it to data entered into the nutritional database for analysis.
Physical activity data were downloaded from the storage database for the parent
study into an Excel spreadsheet before importing into SPSS for analysis. Cleaning the
data involved inspecting for outliers. Any questionable data such as excessive amounts of
physical activity were verified by first checking the original 7D-PAR interview document
where data were recorded and comparing it to data entered into the database for analysis.
Descriptive statistics and analysis of variance (ANOVA) for repeated measure
were used to compare dietary intake and physical activity data at baseline with 3 and 6
months. This was done to determine if differences occurred in nutrient intake and
physical activity following transplantation and if so, when. Pearson product moment
correlations were used to identify relationships between dietary intake, physical activity
and other variables (i.e. age, race, gender and immunosuppressant medications) to weight
gain from baseline to 3 and 6 months. Statistical analyses were performed using
Statistical Package for the Social Sciences, Predictive Analytic Software 18 for Windows
(SPSS/PAW v.18.0). Values of p < 0.05 were considered statistically significant.
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Results
Characteristics of the Sample
Forty four kidney transplant recipients were included in the study. Participant
characteristics at baseline are reflected in Table 4.1.
Mean weight and mean BMI for this group stayed relatively constant from
baseline to 3 months, with an increase in 6 months. Data in Table 4.2 demonstrate
increase in weight, BMI and percent change in both from baseline to 6 months. Mean
weight increased by 9.63 lbs (4.40 kg) and mean BMI showed an increase of 1.47.
Table 4.3 reflects weight by gender and race. More weight was gained by African
American males and females, which was comparable, followed by Caucasian males.
Caucasian females gained the least amount of weight during the 6 months following
transplantation.
At the time of transplant mean creatinine and blood urea nitrogen (BUN) were
5.96 ± 2.89 mg/dL and 36.45 ± 15.42 mg/dL, respectively. Mean hemoglobin at the time
of transplant was 11.31 ± 1.56 gm/dL. Co-morbid conditions pre-transplant were diabetes
mellitus (n = 10, 21%) and hypertension (n = 44). All transplant recipients received
immunosuppression with prednisone at the time of transplant (Table 4.4). Additional
immunosuppression given was MMF, tacrolimus and sirolomus. One participant was
receiving Imuran at baseline, two participants at 3 months and 4 participants at 6 months
were receiving Imuran in addition to other immunosuppressant medications. The majority
of participants received 20 mg daily of prednisone at baseline and were tapered to 5 mg
daily by 3 months post transplantation (Table 4.5).
Data in Table 4.6 demonstrate the incidence of suspected rejection episodes and
the number of hospitalizations following transplantation during the first 6 months after
transplantation (not including the initial hospitalization for transplantation). Seven
participants (16%) experienced suspected rejection episodes of which one was confirmed
with biopsy post transplant. Hospitalizations post transplant were varied in number and
causes.
Dietary Intake
There were no significant differences noted between time points for kilocalorie
and nutrient intakes (Table 4.7). However, kilocalories for the group were about 25%
lower than recommended. Of the macronutrients, total protein was around 25% lower
than recommended, while total fat was about 100% more and total carbohydrate was
about 50% more than recommended. Percent calories from fat was about 23% higher
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Table 4.1 Participant characteristics at baseline (time of transplant) (n = 44).
_________________________________________________________
Characteristic
Baseline (percent)
Age at transplantation years (mean, SD)
49.70 ± 13.09
Range, years
19-70
Males
n (percent)
22 (50%)
Ethnicity n (percent)
African American
26 (59)
Caucasian
18 (41)
Donor source n (percent)
Cadaveric
33 (73)
Living related donor
10 (23)
Diabetes Mellitus
10 (21)
Hypertension
40 (92)

Table 4.2

Weight and body mass index (BMI) at baseline, 3 and 6 months (n = 44).

Weight/BMI

Baseline

3 Month

6 Month

Weight (lbs)

172.46 ±
34.05
127-240

171.21 ±
38.63
112-242.

182.09 ±
38.38
118.8255.9

Weight range
(lbs)
BMI (kg/m2)

26.4 ± 3.8

Percent change
baseline to 6 mo
6%

26.79 ±
28.24 ±
5%
3.92
4.17
19.47-33.47
19.8421.30BMI (kg/m2)
34.85
38.98
range
Abbreviations: BMI, Body Mass Index; M, male; F, female; lbs, pounds; kg/m2,
kilograms per meter squared.
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Table 4.3

Weight and BMI at baseline, and at 3 and 6 months post transplant by race and gender (n = 44).

Weights/BMI
Weight (lbs)

Baseline
3 Months
6 Months
Baseline
3 Months
6 Months
African
African
African
Caucasian
Caucasian
Caucasian
American
American
American
M
F
M
F
M
F
M
F
M
F
M
F
180.10 147.14 181.13 145.25 191.10 158.89 212.31 152.10 213.07 149.21 221.66 155.50
± 27.97 ± 18.75 ± 35.34 24.15 ± ± 33.04 ± 26.06 ± 22.70 ± 20.34 ± 28.25 ± 23.67 ± 31.78 ± 22.93

Weight range
(lbs)

133223

117185

140236

112191

152232

128208

155240

133185

146242

131192

148256

133197

BMI (kg/m2)

26.52
± 1.65

25.02
± 3.43

26.69
± 3.45

25.43
± 4.60

28.19
± 3.0

27.21
± 5.33

29.21
± 1.98

27.06
± 2.76

28.79
± 3.62

26.70
± 3.18

30.03
± 4.07

26.70
± 3.18

BMI (kg/m2)
range

25.1429.15

19.4731.71

21.9229.80

19.8433.73

23.8033.08

21.3038.98

26.7233.47

24.3131.82

20.9932.82

24.1431.82

21.2534.70

24.3032.20

11.1

11.7

9.3

2.4

∆ in lbs
baseline to 6
mo

7
8
4
2
Percent wt
∆ baseline to
6 mo
Abbreviations: BMI, Body Mass Index; M, male; F, female; lbs, pounds; kg/m2, kilograms per meter squared; mo, month; wt, weight;
∆, change.
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Table 4.4 Frequency of prednisone dosages at baseline, and at 3 and 6
months posttransplant (n = 44).
Dosage
50 mg
20 mg
15 mg
12 mg
10 mg
5 mg
2.5 mg
0 mg
Missing

Table 4.5

3 Months
n=0
n=0
n=1
n=0
n=3
n = 42 (89%)
n=0
n=1
n=1

6 Months
n=0
n=0
n=1
n=1
n=1
n = 40 (85%)
n=2
n=1
n=2

Immunosuppression medications by time period (n = 44).

Medication
Prednisone
Mycophenolate
Tacrolimus
Sirolimus
Immuran

Table 4.6

Baseline
n=1
n = 35 (73%)
n=6
n=0
n=4
n=2
n=0
n=0
n=0

Baseline
n = 44 (91%)
n = 43 (98%)
n = 38 (86%)
n = 1 (2%)
n = 1 (2%)

3 Months
n = 44 (91%)
n = 40 (91%)
n = 44 (100%)
n = 2 (5%)
n = 2 (5%)

6 Months
n = 42 (95%)
n = 41 (93%)
n = 41 (93%)
n = 4 (9%)
n = 4 (9%)

Hospitalizations and suspected rejection episodes (n = 35).
Hospitalization/Rejection episode From baseline to 6 months
n (%)
32 (73)
Hospitalizations
7 (16)
Rejection episodes
Confirmed no with biopsy
6 (86)
Confirmed yes with biopsy
1 (14)
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Table 4.7

Nutrient intake at baseline to 3 and 6 months posttransplant (n = 44).

Nutrient
Baseline
3 Months
6 Months
1709.1 ± 566.4
1747.6 ± 608.2
1638.1 ± 531.3
Kilocalorie
70.0 ± 23.4
75.4 ± 28.2
69.1 ± 25.7
Total fat (g)
202.1 ± 86.8
193.8 ± 85.2
188.9 ± 71.4
Total CHO (g)
72.2 ± 22.5
76.8 ± 24.8
69.0 ± 19.7
Total protein(g)
292.7 ± 117.3
320.0 ± 158.0
293.9 ± 161.3
Cholesterol
12.3 ± 6.1
12.9 ± 5.9
12.7 ± 5.6
Total fiber
3.73 ± 3.7
5.00 ± 7.1
3.26 ± 1.8
Vitamin D
55.4 ± 38.8
50.5 ± 33.9
54.1 ± 40.7
Vitamin C
566.6 ± 253.7
605.7 ± 278.9
558.5 ± 62.5
Calcium
1016.3 ± 347.0
3 ± 390
971 ± 300.1
Phosphorus
3134 ± 922.2
3306.6 ± 1290.8
2981.1 ± 248.1
Sodium
2018.3 ± 976.6
1968.5 ± 749.9
1862.1 ± 82.3
Potassium
36.8 ± 6.7
36.8 ± 6.7
37.1 ± 5.6
% Calories fat
43.6 ± 8.3
45.0 ± 7.15
% Calories CHO 45.9 ± 8.2
18.5 ± 5.1
17.9 ± 4.4
% Calories prot 17.7 ± 4.0
1.5 ± .7
1.8 ± 1.1
1.3 ± .6
Omega-3 FAs
Abbreviations: CHO, carbohydrate; prot, protein; cal, calories; FAs, fatty acids; g, gram;
mcg, microgram; mg, milligram.
Note: No significant differences were found in time points.
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while percent calories from carbohydrate was around 10% less than suggested.
Cholesterol intake was in line with recommended intake, while fiber was about 50% less
than recommended.
Of the micronutrients, vitamins D and C, calcium, phosphorus and potassium
were roughly 50% lower than suggested values, while sodium was around 36% higher
than what is recommended. Omega-3 fatty acid intake was in line with recommended
intake values. Table 4.8 shows the percent of participants at or above the DRI for each
nutrient variable at baseline, 3 and 6 months.
Table 4.9 demonstrates significance by race and gender, showed kilocalorie intake
higher in males of both races than females at all time points (p ≤ 0.05). AA males and
females had higher kilocalorie intakes than Caucasians at baseline and 3 months and
fairly comparable intakes at 6 months.
Total fat intake was higher in males from baseline to 3 months (p ≤ 0.035). AA
males and Caucasian males had the highest mean intake of fat and are fairly comparable
between the two groups of male participants. AA females have a higher fat intake
compared to Caucasian females. Means for total fat intake were higher in AAs than in
Caucasians.
Total carbohydrate intake showed higher intakes in males from baseline to 3
months (p ≤ 0.048). Carbohydrate intake was higher in males of both races compared to
females of both races. Mean carbohydrate intake was higher in Caucasian males than AA
males and higher in AA females than in Caucasian females.
No statistical significance was demonstrated in total protein intake according to
race and gender. Higher mean protein intakes were seen at all time points in AA males
compared to Caucasian males and higher in AA females than in Caucasian females.
Higher mean total intake of protein was seen in AA males at all time points.
Cholesterol intake was higher from baseline to 3 months and according to race (p
≤ 0.012) and gender (p ≤ 0.004). Higher mean intake for cholesterol was seen in AA
males compared to Caucasian males and AA and Caucasian females. According to race
and gender, AA males and females have higher mean cholesterol intakes than Caucasian
females.
Total fiber intake was higher according to race (p ≤ 0.035) and significance
according to gender (p ≤ 0.067). Mean for total fiber intake was higher in Caucasian race
than in AA race. Mean total fiber intake was higher in Caucasian males than in Caucasian
females and higher in AA males compared to AA females.
Micronutrient intake of vitamin D and vitamin C were not statistically significant.
However, calcium intake showed for race (p ≤ 0.045), gender (p ≤ 0.003) and race and
gender (p ≤ 0.015). Caucasians had higher mean intake of calcium at all time points
compared to AA participants. Males (both races) had higher mean intake of calcium than
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Table 4.8

Percent at or above Daily Recommended Intake for nutrients (n = 44).

Nutrient

Time point

Kilocalorie

Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months

Total fat
Total CHO
Total protein
Cholesterol
Total fiber
Vitamin D
Vitamin C
Calcium

Daily recommended intake
(DRI)
30 kcal/kg weight
28 kcal/kg weight
28 kcal/kg weight
35 grams
35 grams
35 grams
130 grams
130 grams
130 grams
1.2 grams/kg weight
0.8 grams/kg weight
0.8 grams/kg weight
< 130 grams
< 130 grams
< 130 grams
25-30 grams
25-30 grams
25-30 grams
10 micrograms
10 micrograms
10 micrograms
70 milligrams
70 milligrams
70 milligrams
800-1000 milligrams
800-1000 milligrams
800-1000 milligrams
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Percent at or above DRI
9
7
4
98
93
91
82
73
86
23
70
57
91
91
84
5
5
5
7
9
0
36
23
23
18
18
14

Table 4.8

(continued).

Nutrient

Time point

Phosphorus

Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline
3 months
6 months
Baseline

Sodium
Potassium
Percent calories fat
Percent calories CHO
Percent calories
protein

Daily recommended intake
(DRI)
1200-1500 milligrams
1200-1500 milligrams
1200-1500 milligrams
1000-3000 milligrams
1000-3000 milligrams
1000-3000 milligrams
1000-3000 milligrams
1000-3000 milligrams
1000-3000 milligrams
30 %
30 %
30 %
50%
50%
50%
20%

3 months
20%
6 months
20%
Baseline
1.10 milligrams
Omega-3 fatty acids
3 months
1.10 milligrams
6 months
1.10 milligrams
Abbreviations: kcal, kilocalorie; CHO, carbohydrate; kg, kilogram
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Percent at or above DRI
23
25
20
100
100
100
93
89
89
84
93
86
43
20
18
16
23
32
75
66
57

Table 4.9

Nutrient intake by race and gender at baseline, 3 and 6 months and total (n = 44).

Nutrient/
Threshold
Kilocalorie
30 kcal/kg wt. bl
28 kcal/kg wt. (3 & 6
mo)
Total fat (g)
35 g

Time
point
Bl
3 mo
6 mo

African American
Male
Female
(n = 11)
(n = 15)
1652.3 ± 296.2
1849.9 ± 754.2
1928.1 ± 288.6
1668.9 ± 643.7
1802.4 ± 288.6*
1442.0 ± 662.8

Bl
3 mo
6 mo

71.4 ± 29.1
83.3 ± 24.0*
79.0 ± 19.7

72.9 ± 27.5
75.2 ± 30.3
60.1 ± 26.0

71.1 ± 29.1
78.6 ± 28.3*
78.8 ± 28.5

60.1 ± 10.1
58.8 ± 28.5
57.6 ± 26.0

Total carbohydrate
(g)
130 g

Bl
3 mo
6 mo

176.9 ± 40.1
216.7 ± 85.6*
199.2 ± 44.0

225.6 ± 115.6
173.2 ± 86.9
166.3 ± 92.1

220.9 ± 91.4
221.3 ± 95.9*
223.0 ± 68.0

161.8 ± 35.0
158.6 ± 45.2
168.0 ± 40.4

Total protein(g)
1.2g/kg wt. bl
0.8g/kg wt. (3 & 6
mo)
Cholesterol
< 130 g

Bl
3 mo
6 mo

77.4 ± 24.9
81.4 ± 22.1
76.9 ± 10.5

76.9 ± 24.4
76.9 ± 23.5
61.1 ± 21.0

66.1 ± 22.4
77.2 ± 23.5
76.6 ± 22.7

63.6 ± 9.5
68.8 ± 34.4
61.8 ± 17.1

Bl
3 mo
6 mo

324.4 ± 36.0
368.7 ± 168.0*
337.8 ± 201.2

294.0 ± 45.2
330.6 ± 144.6*
330.4 ± 201.2

282.3 ± 36.0
292.3 ± 124.7*
248.6 ± 117.1

256.4 ± 45.2
264.2 ± 217.2
217.9 ± 135.8

Total fiber
25-30g

Bl
3 mo
6 mo

11.2 ± 3.5
12.4 ± 4.4
13.7 ± 5.0

11.8 ± 7.0
10.1 ± 6.0
9.4 ± 5.3

15.1 ± 7.8
15.7 ± 5.0
16.0 ± 4.7

10.7 ± 5.0
15.1 ± 7.0
12.6 ± 6.0
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Caucasian
Male
(n = 11)
1753.9 ± 621.0
1883.3 ± 667.4
1882.2 ± 524.6*

Female
(n = 7)
1426.4 ± 174.5
1419.6 ± 482.6
1416.5 ± 4

Table 4.9

(continued).

Nutrient/
Threshold
Vitamin D (mcg)
10 mcg

Time
point
Bl
3 mo
6 mo

African American
Male
Female
(n = 11)
(n = 15)
4.2 ± 1.9
2.8 ± 1.4
4.2 ± 1.9
7.3 ± 10.5
4.1 ± 1.7
2.7 ± 1.6

Vitamin C (mg)
70 mg

Bl
3 mo
6 mo

45.9 ± 24.2
54.1 ± 39.7
56.0 ± 49.2

52.3 ± 41.5
51.6 ± 37.0
45.2 ± 34.2

54.1 ± 42.4
47.8 ± 31.2
63.5 ± 41.6

78.8 ± 44.0
46.6 ± 27.0
55.5 ± 40.1

Calcium (mg)
800-1000mg

Bl
3 mo
6 mo

546.1 ± 193.2
568.4 ± 199.3
486.1 ± 99.7

536.4 ± 269.6
515.7 ± 272.0
843.3 ± 327.7

702.7 ± 315.0
836.8 ± 316.3
843.3 ± 327.7

449.9 ± .9
494.3 ± 128.9
470.6 ± 129.4

Phosphorus (mg)
1200-1500mg

Bl
3 mo
6 mo

1041.6 ± 755.7
1019.5 ± 294.5
3.5 ± 232.6

2.0 ± 414.7
1027.8 ± 421.9
834.6 ± 277.6

1029.9 ± 419.6
1198.6 ± 404.5
1173.1 ± 315.0

878.3 ± 179.2
930.9 ± 1655.2
815.7 ± 219.9

Sodium (mg)
1000-3000 mg

Bl
3 mo
6 mo

3157.54 ± 801.9
3521.2 ± 1157.7
3254.2 ± 482.3*

3241.0 ± 1043.3
3109.4 ± 1276.2
2553.5 ± 1.8

3131.3 ± 910.43
3663.0 ± 1222.3
3652.0 ± 1817.7

2871.6 ± 996.5
2831.8 ± 1655.2
2414.22 ± 945.2

Potassium (mg)
1000-3000 mg

Bl
3 mo
6 mo

1817.6 ± 971.5
1727.1 ± 490.0
1955.2 ± 673.0

1928.8 ± 971.5
1899.9 ± 641.0
1581.9 ± 647.2

2386.6 ± 1326.2
2201.2 ± 659.1
2260.5 ± 581.67

1947.1 ± 829.9
2128.6 ± 1303.6
1690.0 ± 708.8
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Caucasian
Male
(n = 11)
2.8 ± 1.3
4.2 ± 1.9
3.7 ± 1.9

Female
(n = 7)
2.6 ± 1.6
5.0 ± 8.4
2.4 ± 1.6

Table 4.9

(continued).

Nutrient/
Threshold
Percent calories fat
30%

Time
point
Bl
3 mo
6 mo

African American
Male
Female
(n = 11)
(n = 15)
38.2 ± 6.4
36.4 ± 6.3
37.9 ± 4.7
39.3 ± .3
39.0 ± 6.0
37.1 ± 4.3

Caucasian
Male
(n = 11)
36.2 ± 9.0
37.3 ± 4.6
36.0 ± 7.4

Female
(n = 7)
36.4 ± 4.7
35.5 ± 5.9
35.5 ± 4.2

Percent calories CHO
50%

BL
3 mo
6mo

42.6 ± 8.2
43.9 ± 8.2
43.5 ± 5.1

46.4 ± 7.8
41.2 ± 10.0
43.5 ± 6.2

48.6 ± 9.3
46.0 ± 5.7
47.5 ± 8.5

45.8 ± 7.3
44.6 ± 8.1
47.0 ± 7.8

Percent calories
protein
20%

Bl
3 mo
6 mo

19.2 ± 4.7
18.1 ± 4.8
17.45 ± 2.5

18.0 ± 4.2
19.4 ± 5.7
19.4 ± 5.9

15.5 ± 2.6
16.9 ± 2.4
16.5 ± 3.2

18.0 ± 3.4
20.0 ± 7.5
17.6 ± 4.4

Bl
1.2 ± 0.5
1.7 ± 0.9
1.5 ± 0.7
1.7 ± 0.6
Omega-3 fatty acids
3 mo
1.5 ± 0.4
2.1 ± 0.8*
1.7 ± .8
1.9 ± 2.0*
(mg)
6 mo
1.4 ± 0.4
1.1 ± 0.6
1.6 ± .7
1.1 ± 0.3
1.10 mg
*p < 0.005 between groups with like symbols.
Abbreviations: kcal/kg wt, kilocalories per kilogram body weight; mo, month; g, grams; Bl, baseline; mcg, micrograms; mg,
milograms; CHO, carbohydrate.
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females (both races) at all time points. Caucasian males had higher mean intakes of
calcium at all time points than Caucasian females and AA males had higher mean intake
of calcium than AA females at all time points. Mean phosphorus intake was higher in
males than females (p ≤ 0.037). Mean sodium intake showed higher intakes in males of
sodium than females (p ≤ 0.034). Similarly, mean intake of potassium was higher in
males than in females (p ≤ 0.029).
Percent calories from fat, carbohydrates and protein did not show statistical
significance. However, Omega-3 fatty acid intake was higher from 3 month to 6 months
(p ≤ 0.010) in gender (p ≤ 0.018). Mean intake of omega 3 fatty acid was higher in
females than males from baseline to 3 months.
Physical Activity
A significant decrease was seen in mean hours of sleep from baseline to 6 month
in pairwise comparisons (p ≤ 0.02). Other physical activity variables did not show
significance for the total group (Table 4.10).
Table 4.11 demonstrates physical activity by race and gender. Hours per day of
light activity did not show significance. However, moderate activity was significant
related to gender from 3 months to 6 months (p ≤ 0.046). Mean hours per day of
moderate activity decreased in males from 3 months to 6 months, whereas moderate
activity for females increased from 3 months to 6 months.
Hours per day of hard activity was significant from 3 months to 6 months (p ≤
0.04) according to race and gender. Mean increases from 3 months to 6 months were seen
in Caucasian females. Hours per day of very hard activity was not reported by any
participants.
Kilocalories for sleep were not significant. Kilocalories for light activity showed
increased kilocalories for light activity in males from 3 months to 6 months (p ≤ 0.028).
Mean increases were seen in males from 3 months to 6 months. Females stayed
comparable at all time points. Kilocalories for moderate and hard activity were not
statistically significant.
Total METs did not show statistical significance. Similarly the number of days of
moderate activity reported in a 7 day period did not show statistical significance.
Relationship between Dietary Intake and Weight Gain
Pearson’s product correlation showed no statistical association between weight
gain at 6 months and kilocalories and macro and micronutrient intake at baseline to 3 and
6 months except for 6 month vitamin D (p ≤ 0.003) (Tables 4.12─4.14).
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Table 4.10

Physical activity from baseline to 6 months (n = 44).

Activity variable
Baseline
3 Months
6 Months
8.3 2.0*
7.9 ± 1.6
7.4 ± 1.9*
Hours/day sleep
15.4 ± 2.4
15.5 ± 1.8
15.6 ± 2.7
Hours/day light
0.4 ± 0.9
0.5 ± 0.8
0.4 ± 0.9
Hours/day moderate
0.04 ± 0.26
0.02 ± 0.1
0.07 ± 0.38
Hours/day hard
0
0
0
Hours/day very hard
8.3 ± 2.0
7.9 ± 1.6
7.4 ± 1.9
Kilocalories/sleep
23.1 ± 3.7
23.3 ± 2.7
24.0 ± 2.7
Kilocalories/light
1.2 ± 2.6
1.7 ± 2.7
1.3 ± 2.7
Kilocalories moderate
0
0
0
Kilocalories hard
0
0
0
Kilocalories very hard
1.9 ± 2.0
2.3 ± 2.5
2.1 ± 2.2
Number of days
moderate activity†
32.7 ± 2.2
32.7 ± 2.4
33.3 ± 7.2
Total METs
*Mean difference is significant at the .05 level when adjusted for multiple comparisons
using Bonferroni between time points with like symbols.
†Number of days of at least 30 minutes of moderate or harder physical activity per week.
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Table 4.11 Physical activity at baseline, 3 and 6 months according to race and gender (n = 44).
Variable
act

Baseline
African
American
M
F
8±2
8±2

3 Months
African
American
M
F
8±1
8±2

6 Months
African
American
M
F
7 ± .9
7±2

Baseline
Caucasian
M
8±2

F
9±2

M
7±1

F
8±3

M
8 ± .8

F
8±3

Hrs/
day light

16 ± 3

15 ± 2

16 ± 2

15 ± 3

16 ± 1

16 ± 3

15 ±
1

16 ±
4

16 ± 2

15 ± 3

15 ± 3

15 ± 4

Hrs/
day mod

.5 ± .9

.1 ± .2

.8 ±
1**

.3 ±
.3*

.4 ±
.3**

.3 ±
.5*

.8 ± 1 .2 ±
.3

.6 ±
.5**

.7 ±
1.*

.2 ±
.2**

1±
2*

Hrs/
day hard

.02 ± .04 .12 ± .44 0

0

.05 ±
.12

0

0

0

.07 ±
.21

.03 ±
.08†

0

.40 ±
.93†

Hrs/ day
sleep

0
Hrs/
day
very hard
Kcal
sleep

8±2

Kcal light 24 ± 4
Kcal mod

2±3

3 Months
Caucasian

6 Months
Caucasian

0

0

0

0

0

0

0

0

0

0

0

8±2

8±1

8±2

7 ± .9

7±2

8±2

9±2

7±1

8±3

8 ± .8

8±3

23 ± 3

23 ± 2

24 ± 3

25 ± 1

24 ± 2

22 ± 2 24 ± 6 23 ± 3

23 ± 4

24 ± 1

22 ± 6

1±1

1±1

1±1

2±4

2±3

.6 ± .6

4 ±6

.40 ± .58 2 ± 4
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.5 ± .9 2 ± 2

Table 4.11 (continued).
Variable
act

3 Months
African
American
M
F
0
0

6 Months
African
American
M
F
0
0

Baseline
Caucasian

3 Months
Caucasian

6 Months
Caucasian

Kcal hard

Baseline
African
American
M
F
0
0

M
0

F
0

M
0

F
0

M
0

F
0

Kcal very hard

0

0

0

0

0

0

0

0

0

0

0

0

Days mod

2±1

2±2

3±2

2±3

3±2

2±2

2±2

2±3

2±1

3±3

2±2

3±3

32 ± 1 33 ± 2
33 ± 1 32 ± 3 33 ± .9 31 ± 8 33 ± 3 32 ± 2 33 ± 2 33 ± 3 35 ± 10 36±6
Total METs
* Hours/day moderate activity significant in females.
**Hours/day moderate activity significant in males.
† Hours/day hard activity significant in Caucasian females.
Abbreviations: ACT, activity; AA, African American; M, male; F, female; lbs, pounds; kg/m2, kilograms per meter squared;
mo, month; Kcal, kilocalorie; Hrs/day, hours per day; mod, moderate; MET,metabolic equivalent.
Note: Mean difference is significant at the .05 level when adjusted for multiple comparisons using Bonferroni between
timepoints with like symbols.
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Table 4.12 Correlations between baseline dietary intake and weight gain at 6
months (n = 44).
Nutrient

Pearson
P-value
correlation
(2-tailed)
0.134
0.387
Kilocalorie
0.073
0.635
Total fat (g)
0.149
0.334
Total CHO (g)
0.151
0.328
Total protein (g)
0.016
0.919
Cholesterol
0.096
0.536
Total fiber
-0.184
0.231
Vitamin D
0.034
0.827
Vitamin C
-0.001
0.996
Calcium
0.099
0.521
Phosphorus
0.174
0.324
Sodium
0.147
0.446
Potassium
-0.124
0.422
Percent calories fat
0.077
0.619
Percent calories carbohydrate
0.044
0.777
Percent calories protein
-0.139
0.367
Omega-3 fatty acids
Note: None of the correlation coefficients is statistically significant at the 0.05 or 0.01
level for the 18 tests shown above.
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Table 4.13 Correlations between 3 month dietary intake and weight gain at 6
months (n = 44).
Nutrient

Pearson
P-value
correlation
(2-tailed)
0.129
0.404
Kilocalorie
0.092
0.550
Total fat (g)
0.138
0.371
Total CHO (g)
0.099
0.522
Total protein (g)
0.017
0.914
Cholesterol
0.099
0.524
Total fiber
.057
0.444
Vitamin D
0.201
0.191
Vitamin C
0.089
0.567
Calcium
0.070
0.653
Phosphorus
0.060
0.698
Sodium
0.058
0.706
Potassium
-0.054
0.728
Percent calories fat
0.077
0.619
Percent calories carbohydrate
0.035
0.823
Percent calories protein
0.047
0.763
Omega-3 fatty acids
Note: None of the correlation coefficients is statistically significant at the 0.05 or 0.01
level for the 18 tests shown above.
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Table 4.14 Correlations between 6 month dietary intake and weight gain at 6
months (n = 44).
Nutrient

Pearson
correlation
0.142
Kilocalorie
0.065
Total fat (g)
0.148
Total CHO (g)
0.217
Total protein (g)
0.200
Cholesterol
-0.011
Total fiber
0.444
Vitamin D
0.014
Vitamin C
0.166
Calcium
0.249
Phosphorus
0.026
Sodium
0.109
Potassium
-0.165
Percent calories fat
0.102
Percent calories carbohydrate
0.050
Percent calories protein
0.080
Omega-3 fatty acids
*Correlation is significant at the 0.05 level (2-tailed).
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P-value
(2-tailed)
0.357
0.673
0.338
0.156
0.193
0.944
0.003*
0.926
0.282
0.103
0.865
0.480
0.285
0.510
0.749
0.606

Relationship between Physical Activity and Weight Gain
Data from Pearson’s product correlation showed no statistical association in the
physical activity variables and weight gain. However, African American race and gender
were significantly associated with 6 month weight. Caucasian race showed a negative
correlation with 6 month weight (r = 0.300, p ≤ 0.048). Female gender was also
negatively correlated with 6 month weight (r = 0.633, p ≤ 0.000).
Relationship among Age, Gender, Race and Medications and Weight Gain
Data from Pearson’s product correlation showed no correlation among age,
gender, race and medications (Table 4.15) to weight gain. However, Spearman’s rho
showed correlation of 6 month MMF (p ≤ 0.041) and baseline tactrolimus (p ≤ 0.014) to
weight gain. Percent weight change was significantly associated with 3 month BMI (p ≤
0.001) and 6 month BMI (p ≤ 0.003).
Discussion
Weight gain after kidney transplantation has been well documented and is a risk
factor for obesity and other co-morbid disorders. Previous studies2,3,7 have shown a
significant amount of weight gained in the first months to years after kidney
transplantation. Weight gain leading to obesity in some participants make them
vulnerable for cardiac disorders,6 the number one cause of death in this population.31
In this study, kilocalorie intake was less than recommended in the total group at
baseline, and at 3 and 6 months post-transplant. Total protein, although lower than
suggested intake, was close to the recommended level at 6 months. Dietary intake was
characterized by an increased total fat and total carbohydrate intake by the sample at the
three time points but with less fiber than is recommended. This higher total fat and total
carbohydrate intake is similar to findings in a study examining dietary intake in kidney
transplant recipient three years after transplantation.125 In contrast to our study, these
researchers found that kilocalorie and protein intakes for their participants were generally
adequate. Furthermore, these researchers were gathering dietary intake data 3 years
following kidney transplant as opposed to during the first 6 months after transplantation
as in our study.
Although similar in age (49.0 ± 12.8 years) and gender (44% female) to the
participants in my study, those kidney transplant recipients that Heaf and colleagues125
used to gathered dietary intake came from Denmark, as opposed to the southern region of
the United States. Comparison of study participants related to socioeconomic status and
access to nutritious foods was not possible.
However, just in Heaf and colleagues’ findings,125 higher intake of fat in males
was similar to fat intake in males in our study. These are clinically significant findings
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Table 4.15 Correlations of medications with weight gain in pounds (n = 44).
Medication time point

Pearson
correlation
-0.164
-0.094
-0.144
0.039
0.070
0.039
0.144
0.050
-0.045

P-value
(2-tailed)
0.287
0.548
0.363
0.801
0.662
0.639
0.358
0.766
0.778

Baseline prednisone
Three month prednisone
Six month prednisone
Baseline tacrolimus
Three month tacrolimus
Six month tacrolimus
Baseline MMF
Three month MMF
Six month MMF
Abbreviations: MMF, mycophenolate mofetil.
Note: None of the correlation coefficients is statistically significant at the 0.05 or 0.01
level for the 9 tests shown above.
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that could place these transplant recipients at risk for accelerated atherosclerosis and
cardiovascular morbidity as seen in other studies.
Similarly, researchers in Mexico report significantly higher ingestion of proteins
and fats than recommended DRIs (p ≤ 0.05) in kidney transplant recipients in eight states
in Mexico. The highest fat intakes were in those states bordering the United States. It was
thought that these findings reflected similar eating habits as the population in the United
States. As would be expected, BMIs were higher in those transplant recipients with the
higher intakes of proteins and fats compared to those with less dietary intake of these
macronutrients.17
Sodium intake was higher than the recommendations at all time points which
could contribute to post transplant hypertension. Since 92% of the participants in this
study were hypertensive at baseline, sodium intake should be at a more conservative
intake of 1 to 3 grams given that hypertension was still present post-transplant.16 At the
same time, these individuals could be at risk for hypertension due to the impaired sodium
excretion effects of calcineurin inhibitors although less hypertensive effects are seen with
tacrolimus.107 Potassium intake was lower than recommended in our study and similar to
others.125 since potassium requirements are varied following transplantation. Lower
potassium intakes in our participants could be attributed lower intakes of fruits and
vegetables containing potassium. Another contributor to a lower potassium intake is
recommendations by the transplant nephrologists for lower intake of potassium-rich
foods since some of the immunosuppressant medications can contribute to hyperkalemia.
Also similar to findings of other researchers, participants in the current study
consumed lower amounts of vitamin D125 and calcium126 which could be contributing
factors to the development of osteoporosis and stress fractures. Similar to kidney
transplant recipients in Denmark127 and Ireland,126 findings suggest, as in our study, that
calcium and vitamin D intakes are inadequate following kidney transplantation in these
samples. In a larger sample with a mean age of 53.6 ± 11.8 years, Ewers and
colleagues127 found that 81% of their sample was deficient in vitamin D and calcium.
Not only are these kidney transplant recipients prone to the development of
osteoporosis and stress fractures due to the inadequate intake of vitamin D and calcium,
increased weight gain could be a contributing factor to these conditions following kidney
transplantation. Kamycheva and colleagues128 in Norway found a significant association
between calcium intake and BMI in males and an association between vitamin D intake
and BMI in both genders. However, further studies need to be done to determine if there
is an association between weight gain and vitamin D deficiency.
Similar to our study, these researchers noted a low intake of dairy products in
their participants’ dietary recalls, thus offering an explanation for the lower amounts of
intake of vitamin D and calcium. One difference in food in Norway and the United
States, is the lack of fortified foods with vitamin D in Norway, possibly explaining one
reason for the lowered intake in that study sample.
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Physical activity results suggest that for the most part, participants did not show
significant variation over time in the physical activity subsets of sleep, light, moderate,
hard and very hard activity. Similar to Nielens and colleagues20who studied activity
levels in renal transplant recipients before transplant and at 1 year following
transplantation, our findings indicate that the majority of the participants increased light
activity post transplantation. Another similarity in our study and Nielens20was that hours
per day for sleep decreased in their participants from baseline to one year, whereas
participants in my study decreased the number of hours of sleep from baseline to 6
months. These findings suggest that some of the hours spent sleeping at baseline (perhaps
related to their health status due to uremia prior to transplantation), are now being spent
in light physical activities.
Unlike the study by Nielens,20 my study did show that kilocalories for light
activity indicated mean increased only in males from 3 to 6 months, with females
remaining comparable at all time points. Also kilocalories for moderate and hard activity
were not significantly different from each time point.
Although no significant relationships were demonstrated among dietary intake,
physical activity and age, gender, race and immunosuppressant medications, clinical
significance exists when reviewing the high amounts of total fat and carbohydrates at all
time points. These higher macronutrient intakes, coupled with low levels of physical
activity, could put these participants at risk for weight gain. It is also important to note
that this group of participants also had low intakes of total fiber that could contribute to
weight gain. Low levels of micronutrients (i.e., calcium, vitamin D) could put them at
risk for bone deterioration following transplantation.
Similar to other studies, weight gain has been demonstrated in individuals who
may have a genetic predisposition to weight gain related to ethnicity.4,7,129 Although in
our study African American males and females tended to gain more weight in the first 6
months after kidney transplant, a significant difference was not demonstrated as in other
studies. Since African American participants gained more weight in this study than
Caucasian males and females, these two groups could be more at risk for weight gain
following kidney transplantation. Along with being at risk for obesity, this group of
transplant recipients may also develop undesirable conditions such as CAD,
hypertension, hyperlidemia and new onset diabetes mellitus.2,1,62
Limitations
Since the dietary intake and physical activity data are self-reported, there are
some limiting factors associated with this type of data collection. Memory of the
preceding 24 hour period for the dietary intake recall and the 7 days preceding the
physical activity recall could be seen as limitations of this study.
Also, dietary baseline data, obtained approximately 2 weeks following kidney
transplantation, could be different than data obtained in the weeks or months preceding
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transplantation. Baseline physical activity data, also collected about 2 weeks following
transplantation, reflects the participants’ recall of their physical activity just prior to
kidney transplantation.
Baseline steroid dosages were higher than at 3 and 6 months which could increase
appetite during the first weeks following transplantation. Thus, steroid use during the
early period following transplantation could have affected an increase in dietary intake.
A factor that may affect the generalizability of this study to a larger kidney
transplant population is the small sample size. Furthermore, the study participants were
not randomly selected but were all consented in a larger parent study from the same
transplant center in the mid-south area representing participants from Tennessee,
Arkansas and Mississippi, predominately.
Conclusions
Kidney transplant recipients are at risk for weight gain from a number of factors.
However, little consideration has been given to what kidney transplant recipients are
eating and the effect dietary intake has on weight gain in this population. High intakes of
total fat and carbohydrates, along with low intake of fiber put these kidney transplant
recipients at risk for co-morbid disorders as well. Physical activity data from this study
suggest that kidney transplant recipients are not changing their physical activity levels
significantly by 6 months following transplantation compared to their baseline activity
levels.
The implications of these findings are that dietary assessments, including 24 hour
dietary intake, and physical activity assessments should continue to be monitored for at
least one year or longer following transplantation, to examine effects of dietary intake
and physical activity on weight gain. Dietary and physical activity data from this study
suggest the need for interventions to teach individuals who have undergone kidney
transplantation, dietary and physical activity factors that could prevent weight gain in the
post transplant period. Nurses, in collaboration with transplant dietitians and other
members of the transplant team, can be instrumental in designing interventions that will
accomplish short term goals of weight management, while employing gradual dietary
changes in the levels of fat, carbohydrates and fiber that are more in line with
recommended values. Along with these dietary intake changes, physical activity tailored
to each transplant recipient could be developed and encouraged with follow-up during the
intervention period.
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